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INTRODUCTION 
Explanation of Dissertation Format 
This dissertation is written in the alternate format as permitted by 
the Graduate College. The main part is divided into five sections. Three 
of these sections, I, III and IV, correspond to research papers already 
published. Section V corresponds to a research paper submitted for publi­
cation, and Section II contains data not intended for publication but con­
sidered relevant to this dissertation. The papers report on some of the 
research the author has performed as a graduate student, under the super­
vision of his major professor. Dr. Mirjana Randid, and constitute a pro­
gression of experimental results obtained during the course of five years. 
In addition to the five sections, the dissertation includes an objective, 
a literature review, the rationale for performing the experiments, a short 
discussion, a summary and a list of literature cited. 
Objective 
The purpose of this project was to examine the possible actions of 
four neuroactive peptides--substance P, methionine-enkaphalin, somato­
statin and neurotensin—in the regulation of excitability of mammalian 
spinal neurons. Specifically, functionally identified dorsal horn and 
dorsal spinocerebellar tract neurons in the cat spinal cord in vivo, and 
dorsal horn neurons in rat spinal cord slices in vitro were studied. 
Neuronal activity was monitored extracellularly while the neuropeptides 
were applied by iontophoresis. It was felt that such an approach would 
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provide new information about the possible physiological role of these 
neuropeptides in synaptic transmission, and would help in determining a 
more precise site of their action in the spinal dorsal horn. 
Literature Review 
In the central nervous system (CNS), peptides have long been con­
sidered to play a role mainly in neuroendocrine interactions. Lately, 
however, many have been additionally implicated in synaptic transmission. 
Whether they are newly discovered neurotransmitters, or have a role as 
"neuromodulators," remains to be established, especially since Dale's 
postulate (Dale, 1935) of one transmitter neurons has recently been chal­
lenged. Nevertheless, synaptic transmission seems more complicated than 
previously thought, and the peptides have brought much excitement and 
novelty to its study. 
Substance P 
History, distribution and biological actions Substance P (SP) is 
the doyen of putative peptide transmitters. The unusual name, P stands 
for preparation, was originally used to denote the activity of a particu­
lar tissue extract (Gaddum and Schild, 1934), and this noncommittal term 
has persisted, appropriately perhaps, since the peptide is still in search 
of a function. 
SP was accidentally discovered in 1931 when von Euler and Gaddum, 
during a search for acetylcholine (ACh), isolated a material from the 
brain and small intestine of the horse which caused hypotension in vivo 
and contraction of gut smooth muscle in vitro (von Euler and Gaddum, 
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1931). Except for determining that the material was probably a peptide, 
since its activity was destroyed by trypsin (von Euler, 1936), not much 
attention was paid to it for almost 20 years. Then Pernow (1953) exten­
sively studied the actions of partially purified SP on smooth muscle, and 
Lembeck (1953) looked at its distribution in the nervous system. Lembeck 
found that spinal dorsal roots contained "ten times more" SP than ventral 
roots, and he noted that certain dorsal root extracts caused potent vaso­
dilation (as previously reported by Hellauer and Umrath, 1948) and gut 
contraction. Guided by Dale's principle (Dale, 1935), and the proposal 
that the vasodilatory activity of dorsal root extracts represented the 
action of the excitatory transmitter of sensory fibers (Hellauer and 
Umrath, 1948), Lembeck (1953) was the first to propose that SP might be 
the transmitter of primary sensory neurons. 
Many attempts were subsequently directed at obtaining SP in pure 
form, but this was accomplished, again accidentally, only in 1970. Leeman 
and Hammerschlag (1967), searching for corticotropin releasing factor, 
isolated a sialogogic peptide from bovine hypothalami. Upon purification 
and determination of its physico-chemical characteristics, it became clear 
the peptide was SP (Chang and Leeman, 1970). Chang et al. (1971) subse­
quently determined the primary amino acid sequence of SP (Arg-Pro-Lys-
Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NHg)» and Tregear et al. (1971) synthe­
sized it. The way was thus open for detailed studies on SP distribution 
and function. 
SP is widely distributed in body tissues. In general, the distribu­
tion correlates well with the nerve supply although the peptide also has 
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been localized in endocrine-like cells of the gut (see Skrabanek and 
Powell, 1978). Within the CNS, the distribution of SP is uneven. Highest 
SP concentrations are found in the superficial dorsal horn of the spinal 
cord and trigeminal nucleus, reticular part of the substantia nigra, 
hypothalamus, interpeduncular nucleus and amygdala. Little peptide is 
present in the cerebral cortex, and almost none in the cerebellum (see 
Cuello and Kanazawa, 1978; Ljungdahl et al., 1978). 
SP has multiple actions in the body. The peptide causes dilation of 
vascular beds in all organs tested (gut, spleen, kidney, myocardium), 
hypotension, contraction of gut and tracheal smooth muscle, salivation, 
etc. (see Skrabanek and Powell, 1978). However, due to the peptide's 
almost exclusive presence within nervous tissue, most of the speculations 
about a possible physiological function for SP center on a role in synap­
tic transmission. 
A putative neurotransmitter has to satisfy a set of criteria to be 
identified as a synaptic transmitter (for a detailed discussion of these 
criteria, see Herman, 1966; Orrego, 1979). First, the presence of the 
putative transmitter at synapses of distinct neuronal pathways has to be 
established. This requires localization of the suspected transmitter in 
synaptic vesicles within presynaptic terminals, as well as demonstration 
of its biosynthesis in the presynaptic neuron, uptake mechanisms and/or 
inactivating enzymes at the synapse, and "receptor" sites on the post­
synaptic neuron. Then, the transmitter must be released at the synapse 
following presynpatic fiber activation in a calcium-dependent fashion. 
More important, its action on the postsynaptic membrane must mimic that of 
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the endogenous transmitter in producing identical changes in membrane 
potential and conductance to ions. Finally, identical pharmacological 
effects of drugs potentiating or blocking postsynaptic responses to both 
the endogenously released substance and the putative transmitter must be 
demonstrated. 
Presently, evidence has been obtained for SP to satisfy at least 
some of these criteria in four central pathways: (1) primary afferents 
(PAs) to spinal corid or trigeminal nucleus, (2) habenula to inter­
peduncular nucleus, (3) striatum to substantia nigra, and (4) an intrinsic 
amygdaloid pathway (see Skrabanek and Powell, 1978; Nicoll et al., 1980). 
Due to our interest in, and studies of, synaptic transmission at the level 
of the spinal cord, in the remainder of this review, only evidence regard­
ing the PA path will be presented. For more detailed information on SP, 
the reader is referred to several recent reviews. The most comprehensive 
is the volume by Skrabanek and Powell (1978) which provides a brief sum­
mary of almost every paper on SP published up to 1977. SP also is dis­
cussed at length in the volume edited by von Euler and Pernow (1977), 
which is a collection of papers dealing with various aspects of SP re­
search and presented at the 37th Nobel Symposium, and in the review by 
Mroz and Leeman (1977). An excellent recent review on the possible role 
of SP in synaptic transmission is that by Nicoll et al. (1980). 
Excitatory transmitter candidate of primary sensory neurons That 
SP is present in PAs, their cell bodies in spinal ganglia, and their 
terminations in the spinal cord has been well-established. In spinal 
gauglia, about 20% of the small, B-type neurons contain SP (Hokfelt 
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et al., 1976; Chan-Palay and Palay, 1977). In the dorsal horn, the high­
est density of immunoreactive SP fibers occurs in Lissauer's tract, super­
ficial dorsal horn, i.e., Rexed's (1952) laminae I-II, and adjacent parts 
of the dorsolateral funiculus (DLF). Less SP is present in dorsal horn 
laminae IV-VI, the area around the central canal and the ventral horn 
(Hokfelt et al., 1975b; Takahashi and Otsuka, 1975; Barber et al., 1979). 
Peripheral nerve section, dorsal root ligation, or dorsal rhizotomy all 
cause a marked reduction of SP in the ipsilateral dorsal horn (Takahashi 
and Otsuka, 1975; Hokfelt et al., 1977; Barber et al., 1979; Jessell 
et al., 1979b; Tessler et al., 1980). The SP content of the ventral horn 
and intermediate gray remains, however, unaffected following these proce­
dures suggesting that only in the dorsal horn is SP of PA origin. The 
peptide in other spinal cord areas probably originates from intrinsic and/ 
or descending pathways. 
Fractionation studies on brain homogenates have localized SP in the 
synaptosomal subcellular fraction (e.g., Duffy et al., 1975). Within 
axons, mostly unmyelinated and finely myelinated, and PA terminals in 
laminae I-II of the dorsal horn SP has been associated with both small 
(45-60 nm) agranular and large (80-300 nm) granular synaptic vesicles 
(Chan-Palay and Palay, 1977; Cuello et al., 1977; Pelletier et al., 1977; 
Pickel et al., 1977; Barber et al., 1979). 
Little is known about SP biosynthesis or mode of deactivation. 
Studies of polypeptide hormones have shown that smaller, active peptides 
are usually derived by enzymatic cleavage of specific peptide bonds from 
large, biologically inactive prohormones which are formed by RNA-directed 
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ribosomal synthesis (see Steiner, 1976). Therefore, not only SP but most, 
if not all, neuropeptides are thought to be formed in a similar manner. 
Recently, Harmar et al. (1980) have given support to this notion by re­
porting that isolated dorsal root ganglion cells incorporated ^^S-
methionine into SP following a 1-2 hour delay. Cyclohexamide (a protein 
synthesis inhibitor) blocked label incorporation and this finding sug­
gested that SP was synthesized by a ribosomal process. Since it has been 
proposed that all peptides synthesized by membrane bound ribosomes should 
have a 30-40 amino acid signal sequence (Blobel et al., 1979), the latent 
period was explained by Harmar et al. as time needed for the conversion 
from an SP precursor to the active peptide, analogous to the process of 
vasopressin and oxytocin biosynthesis (Gainer et al., 1977). 
There is no experimental evidence at present to suggest the existence 
of re-uptake mechanisms for SP in axon terminals (see Nicoll et al., 
1980). It is reasonable to expect then that inactivating enzymes are 
present at the synapse in order to terminate the peptide's action. How­
ever, to date, no specific SP-inactivating enzyme has been isolated. A 
variety of endopeptidases in different brain regions cleave SP but not 
exclusively since somatostatin (SS), neurotensin (NT), etc., also are in­
activated by the same enzymes (see Skrabanek and Powell, 1978). 
Release of SP in the rat hemisected spinal cord in vitro has been 
observed following repetitive stimulation of dorsal roots, or depolariza­
tion of their terminals with (55 mM) bathing media; the release was 
calcium-dependent since it was abolished in a low Ca^^, high Mg^^ super-
fusing solution (Otsuka and Konishi, 1976). Similarly, potassium-evoked 
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and calcium-dependent SP release has been observed in spinal cord slices 
(Gamse et al., 1979), and sensory neurons in dissociated cell cultures 
(Mudge et al., 1979). SP release in vivo also has been demonstrated; the 
release could be evoked by electrical activation of only the small diame­
ter PAs in the sciatic nerve, and again, it was calcium-dependent (Jessell 
et al., 1979a). 
Once released, it is assumed that SP interacts with "receptors" lo­
cated on the postsynaptic neuronal membrane to cause an effect, although 
to date little is known about the properties or precise location of these 
receptors in the CNS (see Nicoll et al., 1980). 
The presumed postsynaptic action of SP on spinal neurons has been 
studied both in vitro and in vivo. Otsuka and collaborators were the 
first to report that bovine dorsal root extracts, the active principle of 
which was later identified as SP (Takahashi et al., 1974), exerted a 
potent depolarizing action on motoneurons of the frog (Otsuka et al., 
1972) and newborn rat spinal cord (Konishi and Otsuka, 1974) in vitro. 
The effect appeared to be exerted directly on the motoneuronal membrane, 
since it persisted when synaptic transmission was blocked with tetrodo-
toxin (TTX), and was 200 (frog) to 10,000 (rat) times greater than the 
depolarizing effect of L-glutamate (GLU, another PA transmitter candi­
date). Intracellular recordings from the motoneurons revealed that the 
depolarization was associated with a decrease in membrane input resistance 
(increase in conductance), and the reversal potential was more positive 
than the resting potential. This was similar to conductance changes ob­
served in motoneurons following natural stimulation of the PAs, and was 
9 
suggestive of Na^ involvement (Nicoll, 1976; Otsuka and Konishi, 1977; but 
see below). 
When SP was applied by iontophoresis to cat dorsal horn neurons in 
vivo (Henry et al., 1975; Henry, 1976; Randic and Miletic, 1976, 1977), 
the peptide was observed to have a strong, but slow, excitatory action of 
delayed onset (10-30 seconds) and prolonged duration. Subsequent intra­
cellular recordings from dorsal horn units in laminae IV and V, and moto­
neurons, confirmed the potent and slow depolarization (Krnjevic, 1977; 
Sastry, 1979b; Zieglgansberger and Tulloch, 1979a). However, in disagree­
ment with in vitro studies, Krnjevic (1977) reported that the depolariza­
tion was associated with an increase in membrane input resistance (de­
crease in conductance), and a reversal potential which was more negative 
than the resting potential and which was suggestive of or CI" involve­
ment. Sastry (1979b) and Zieglgansberger and Tulloch (1979a), on the 
other hand, reported no observable change in membrane input resistance at 
all. Moreover, confusing the issue further, Vincent and Barker (1979), in 
a study of mouse spinal neurons in culture, reported that iontophoretical-
ly applied SP had two different modes of action. In some units, the pep­
tide caused a rapid depolarization of the neuronal membrane accompanied by 
a decrease in membrane input resistance (increase in conductance), and 
both of these actions desensitized within one second. In other neurons, 
however, SP caused a nondesensitizing and reversible depression of GLU 
excitatory responses without causing any change in the properties of the 
postsynaptic membrane. The authors suggested that the first SP action was 
consistent with a transmitter-like effect. The second action, on the 
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other hand, seemed modulatory in nature, i.e., the peptide modulated the 
efficacy of synaptic transmission by interacting with the "primary" 
neurotransmitter rather than being itself responsible for initiating 
transmission. Such modulatory action of SP has been postulated before 
(see Krnjevic, 1977), and was given anatomical support with the co-locali­
zation of SP and 5-hydroxytryptamine (5-HT), or other still unidentified 
substances, within the same neuron (see Nicoll et al., 1980). This dis­
agreement regarding the crucial "identity of action" criterion for central 
synaptic transmission remains unresolved. 
That SP excitatory action is limited to postsynaptic sites is also 
unresolved. Conceivably, the peptide could be involved in regulation of 
PA input by acting presynaptically. Presynaptic inhibition, and its 
electrophysiological correlate primary afferent depolarization (PAD), has 
been described for large diameter, myelinated PA fibers (see Schmidt, 
1971), although the chemical mediator of this process is at present un­
known. It is of interest, therefore, that SP has been observed to cause a 
prolonged depolarization of PAs (Nicoll, 1976; Randic and Miletic, 1978a), 
and to modify the electrical excitability of single intraspinal cutaneous 
PAs by producing either an increase or a decrease in their threshold for 
antidromic (AD) activation (Randic, 1981). Thus, it would be reasonable 
to assume that SP might produce PAD in some PAs. However, picrotoxin, 
which blocks PAD, does not block the peptide's action (Nicoll, 1976). 
Moreover, it is of interest that very recent reports fail to observe more 
than a few axo-axonic synapses of SP-containing PAs in laminae I-1II of 
the spinal cord (de Lanerolle and LaMotte, 1980; Leeman et al., 1980) and 
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spinal trigeminal nucleus (Sumal et al., 1980). Rather, the SP afferents 
are seen to make mostly axo-dendritic contacts with dorsal horn inter-
neurons. Since axo-axonic synapses have been proposed to provide the 
morphological basis for presynaptic inhibition (Gray, 1962), the possible 
presynaptic role of SP remains to be clarified. 
The last, and least satisfied, criterion for transmitter action of SP 
relates to the pharmacology of synaptic effects. Several substances, some 
of them SP analogs, have been employed in attempts to specifically antago­
nize the peptide's actions and observe whether the endogenously released 
PA transmitter would be similarly affected. However, most of these puta­
tive antagonists appeared to act nonspecifically. Thus, baclofen (3-4-
chlorophenyl-Y-aminobutyric acid, Lioresal), although inhibiting SP action 
on spinal neurons, also antagonizes that of ACh, GLU, etc. (see Skrabanek 
and Powell, 1978). Yet, some progress seems to have been made recently in 
2 the search for an SP specific antagonist. The peptide's analog [D-Pro , 
D-Trp^'^]-SP has been claimed to antagonize some of the SP peripheral ac­
tions, e.g., salivation, vasodilation.^ It remains to be determined 
whether SP actions in the CNS will be similarly affected. 
Possible role of SP in spinal nociceptive pathways Lately, histo-
chemical, pharmacological and electrophysiological evidence has accumulat­
ed to indicate that SP is present only in a certain population of primary 
sensory neurons—those involved in nociceptive information signalling. 
^Hokfelt, T. 1980. Peptide neurons: A new class of neurons or old 
neurons with a new content? Special lecture delivered at the 10th Annual 
Meeting of the Society of Neuroscience held in Cincinnati, Ohio November 
9-14, 1980. 
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It seems well-established that SP is present in about 20% of the 
small dorsal root ganglion cells and their probably unmyelinated (C) and 
finely myelinated (A6) axons and terminals both in the skin and the dorsal 
horn of the spinal cord (Hokfelt et al., 1976; Chan-Palay and Palay, 
1977). Most of these small diameter PAs are considered to carry informa­
tion from skin receptors adequately activated by noxious stimuli, i.e., 
stimuli of such intensity that threaten to do, or actually do, damage (see 
Kerr, 1978). It is apparently upon these nociceptive PAs that capsaicin, 
a homovanillic acid derivative (8-methyl-N-vanillyl-6-noneamide) exerts 
its action. (For a detailed discussion of the interaction between SP and 
capsaicin, see the excellent review by Virus and Gebhart, 1979.) 
Capsaicin appears to completely abolish neurogenic inflammation in­
duced either by chemical or AD electrical stimulation of sensory nerves 
(Jancso-Gabor and Szolcsânyi, 1972; Gamse et al., 1980a). This action of 
capsaicin has been attributed to the inhibition of release of the mediator 
of inflammation which is thought by some to be SP (Jancsd-Gctbor and 
Szolcsanyi, 1972; Lembeck and Holzer, 1979; Gamse et al., 1980a). Acute 
capsaicin treatment causes an apparently selective increase in the firing 
rate of peripheral sensory nerves involved in nociception (Pdrszâsz and 
Jancsd, 1959), and produces a calcium-dependent release of SP both in vivo 
and in vitro (see Virus and Gebhart, 1979; Nicoll et al., 1980). Chronic 
capsaicin treatment of newborn rats causes both an extensive axonal de­
generation in the dorsal horn, especially lamina II (Jancso et al., 1977), 
and a marked depletion of SP in laminae I-II (Gasparovic et al., 1964; 
Jancso and Knyihar, 1975; Jessell et al., 1978). The axonal degeneration 
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and SP depletion in the dorsal horn are both accompanied by a prolonged 
insensitivity of the treated animals to nociceptive stimulation (Jancso 
et al., 1977; Yaksh et al., 1979; Hayes and Tyers, 1980; Nagy et al 
1980). Capsaicin, SP and nociception seem thus interconnected. 
Moreover, additional evidence has been obtained to point to an inter­
relationship between SP and spinal nociception. When applied to the 
cornea or exposed blister base, SP causes pain in humans (Hellauer, 1953; 
Bisset and Lewis, 1962). Following SP iontophoresis, a prolonged after-
discharge, reminiscent of the "wind up" phenomenon attributed to C affer­
ent input, is almost always observed in dorsal horn neurons (Henry et al., 
1975; Randic and Miletic, 1976, 1977). After unilaterial rhizotomy, super­
sensitivity to iontophoretic application of eledoisin related peptide 
(ERP, an SP analog) develops (Wright and Roberts, 1978) which appears to 
be a result of an increase in receptor sites rather than receptor affinity 
(Nakata et al., 1979). In his iontophoretic study in vivo, Henry (1976) 
reported that about half of the tested wide dynamic range neurons (WDR, 
units which are activated by both noxious and innocuous stimulation) in 
laminae IV and V were excited by SP. The peptide facilitated the re­
sponses of these nocioceptive neurons to adequate stimuli; those units 
having no nociceptive PA input were not affected by SP. Lastly, we also 
have tested SP, applied by inotophoresis in vivo, but onto the neurons in 
laminae I-III which are principally excited either by noxious or by in­
nocuous stimuli, and which are considered to receive monosynaptic, rather 
than di- or polysynaptic, PA input (in Henry's study the spinal neurons 
tested were 2nd or even 3rd order). We found that SP caused a strong 
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excitation of all tested units activated exclusively by noxious stimuli 
and receiving an input in AS and/or C fibers. The peptide facilitated the 
responses of the nociceptive neurons to adequate stimulation, and SP 
seemed to have no effect at all on most of the units activated only by 
innocuous stimuli (Randic and Miletic, 1976, 1977; see Section I). 
Therefore, a casual relationship between SP and spinal nociceptive 
pathways has been suggested. The details of the relationship remain, how­
ever, to be elucidated. 
Enkephalins 
History, distribution and biological actions Unlike SP, or 
somatostatin (SS) and neurotensin (NT), the enkephalins were discovered as 
a result of a purposeful search for the endogenous ligand of opiate re­
ceptors. The impetus for this search of "brain's own morphine" was given 
by the demonstration of opiate receptors in animal brains. 
Ideas about the existence of such receptors were a result of research 
in opioid mechanisms of action and the realization, over the years, that 
opioids apparently exert their characteristic effects by interacting with 
specific receptors (see Jaffe and Martin, 1980). Goldstein et al. (1971) 
were the first to establish a set of criteria for stereospecificity of 
opiate binding to their receptors. Soon thereafter Pert and Snyder 
(1973), Simon et al. (1973) and Terenius (1973) independently demonstrated 
the presence of high-affinity, stereospecific opiate receptors in brain 
tissue. The subsequent search for the endogenous ligand of these re­
ceptors was a logical extension of such findings. Hughes (1975) was the 
first to report the isolation of a morphine-like compound, and later in a 
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collaborative effort, establish that the substance was actually a mixture 
of two pentapeptides differing only in their terminal amino acid but, 
once synthesized, having properties identical to those of morphine (Hughes 
et al., 1975a,b). The peptides were named methionine-enkephalin (Tyr-
Gly-Gly-Phe-Met) and leucine-enkaphalin (Tyr-Gly-Gly-Phe-Leu), the pre­
fixes denoting their differing terminal amino acid (Hughes et al., 1975a), 
and soon thereafter their distribution within the CNS was confirmed 
(Pasternak et al., 1975). Hughes et al. (1975a) recognized from the be­
ginning that the methionine-enkephalin (ME) sequence was identical to 
residues 61-65 of 3-lipotropin, a 91-amino acid polypeptide hormone previ­
ously isolated from the pituitary gland (Birk and Li, 1964). Subsequent­
ly, it was demonstrated that a whole family of endogenous opioids exists. 
They were given the collective name "endorphins," and a veritable explo­
sion in opioid research followed of which the scope and size of the mush­
rooming literature of the past five years stands witness. 
The enkephalins are widely distributed in body tissues. Both ME and 
leucine-enkephalin (LE) are found in high concentrations in the central 
and peripheral nervous system, sympathetic ganglia, gastrointestinal 
tract, pancreas, urinary tract (see Johansson et al., 1978*, Snyder et al., 
1978) and adrenal medulla (Yang et al., 1980). 
Pharmacological actions of the enkephalins and their analogs are 
morphine-like, i.e., they have analgesic properties, produce constipation 
and respiratory depression, affect body temperature, interact with other 
neurotransmitters, produce catalepsy and catatonia as well as marked 
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changes in mood, behavior and the electroencephalogram (EEG), influence 
learning and memory, and, interestingly, demonstrate tolerance and de­
pendence upon repeated administration (see Adler, 1980). 
The remainder of the review will deal only with evidence regarding 
the possible role of the enkephalins in synaptic transmission. The reader 
is referred to numerous review articles for more detailed information 
about not only the enkephalins but the endorphins and other opioids as 
well. Some of the recent sources are: Costa and Trabucchi (1978), Hughes 
(1978), Miller (1978), Terenius (1978), Beaumont and Hughes (1979), Loh 
and Ross (1979), North (1979), Adler (1980), Miller and Pickel (1980) and 
Zieglgansberger (1980). 
The enkephalins are distributed throughout the CNS, although differ­
ent brain regions widely differ in their enkephalin content. The globus 
pallidus, amygdala, nucleus accumbens, hypothalamus, central gray and 
superficial dorsal horn of both the spinal cord and caudal trigeminal 
nucleus are highest in ME and LE content, with the cerebellum containing 
little, if any, enkephalin (see Adler, 1980; Miller and Pickel, 1980). 
This enkephalin distribution parallels closely, and not surprisingly, that 
of opiate receptors (see Kuh'ar and Uhl,,1979). All areas that contain ME 
also contain LE, but usually the former is found in higher concentration 
within a given area, and the ratio of the two peptides differs from area 
to area (see Miller and Cuatrecasas, 1979). ME and LE appear, however, 
not to be located in the same neuron (Larsson et al., 1979). Such distri­
bution of the enkephalins gave rise early to speculations about a possible 
role in synaptic transmission. There are apparently several CNS regions 
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in which the peptides might be involved as neurotransmitters or neuro­
modulators, and one of these regions is the superficial dorsal horn 
(lamine I-III) of the spinal cord. 
Evidence for enkephalin role in synaptic transmission in the dorsal 
horn The presence of both ME and LE in the dorsal horn appears well-
established (see Elde et al., 1978; Johansson et al., 1978; Snyder et al., 
1978; Miller and Pickel, 1980). Laminae I and II (the latter also is 
known as the substantia gelatinosa, SG) show the highest concentration of 
enkephalin immunoreactivity in the spinal cord. Laminae IV and V as well 
as areas around the central canal appear to contain less of the peptides. 
This distribution of the opioids in the dorsal horn once again parallels 
closely that of opiate receptors (LaMotte et al., 1976; Atweh and Kuhar, 
1977). 
Subcellularly the enkephalins have been found in synaptosomal frac­
tions of rat brain homogenates (Simantov et al., 1976), and have recently 
been localized, by electron microscopy, to synaptic vesicles in axon 
terminals (Pickel et al., 1979). The axon terminals seem to contain both 
a few large (75-100 nm) dense core vesicles, and many small (40-60 nm) 
clear vesicles; the enkephalins are localized within the lumen of the 
large vesicles, and are seen to form a rim around the small vesicles. The 
content of these latter vesicles is not known at present, but the observa­
tion raises intriguing possibilities. 
Enkephalin biosynthesis resembles that of the other neuropeptides. 
ME and LE are apparently formed by enzymatic cleavage of larger opioid 
precursors. Sosa et al. (1977) reported a linear incorporation of label 
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into the enkephalins only after an initial lag period of 1-2 hours follow-
3 ing incubation with H-tyrosine. Cyclohexamide or puromycin blocked label 
incorporation, but only when added during the labelling period, indicat­
ing, perhaps, a specific action on ribosomal protein synthesis. The lag 
period, as suggested by Sosa et al., might represent the time taken for 
the synthesis of, and conversion from, a larger prohormone, analogous to 
oxytocin and vasopressin biosynthesis (Gainer et al., 1977). 
Since the entire ME sequence was found to be a part of the 3-endor-
phin molecule, the larger opioid peptide was thought to be a precursor of 
ME. This is now considered unlikely, due to the different distribution of 
ME-containing and 3-endorphin-containing neurons, and the discovery of 
smaller opioid peptides, containing repetitions of both the ME and LE se­
quence, within enkephalinergic cells of the adrenal medulla (see Beaumont 
and Hughes, 1979; Miller and Pickel, 1980; Yang et al., 1980). It is of 
interest, though, that an enzyme in the rat brain has been recently re­
ported to selectively cleave the Met^^-Thr^® bond in 3-endorphin to gen­
erate ME (Koida et al., 1979). More studies are obviously needed to re­
solve the matter. 
It is known, on the other hand, that 3-endorphin is generated from 
3-lipotropin, and that the latter peptide is also a common precursor of 
a- and y-endorphin, as well as of melanocyte stimulating hormone (MSH) 
(see Beaumont and Hughes, 1979). It now appears that 3-lipotropin is it­
self derived from an even larger polypeptide, the 31,000 molecular weight 
"pro-opio-melanocortin" which serves as a prohormone of both 3-lipotropin 
and adrenocorticotropic hormone (ACTH) (see Chretien et al., 1979). 
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Less is known about LE precursors. Two peptides have been reported 
to contain the LE sequence within the CNS. One is a 13-amino acid potent 
opioid named dynorphin (Goldstein et al., 1979); the other, apparently 
bearing no relationship to g-endorphin, is a-neo-endorphin (Kanagawa and 
Matsuo, 1980). Whether these peptides are indeed LE precursors is subject 
of further study. 
The enkephalins appear to be inactivated by enzymatic hydrolysis. 
The rapid degradation possibly involves an aminopeptidase, which cleaves 
the N-terminal Tyr^ (Hambrook et al., 1976), or a dipeptydyl carboxy-
peptidase, which cleaves the C-terminal Phe^-Met^ or Phe^-Leu^, and which 
may (Bennuck and Marks, 1979) or may not (Swerts et al., 1979) be identi­
cal with brain "angiotensin-converting" enzyme. 
A potassium-evoked, calcium-dependent release of enkephalins from 
synaptosomal preparations or brain slices in vitro has been demonstrated 
by several researchers (see Beaumont and Hughes, 1979). Recently, ME re­
lease, again potassium-evoked and calcium-dependent, has been reported 
from the rat spinal cord in vivo (Yaksh and Elde, 1980). 
That ME and LE exert their effects by binding to specific receptors 
seems well-established. However, isolation and purification of the pre­
sumably membrane-bound opiate receptors have proved difficult (see Simon, 
1979). Moreover, four different subtypes of opiate receptors, designated 
6, K, y, and a, have been postulated to exist in body tissues, and the 
various opioid agonists and antagonists would bind with greater affinity 
to one or the other subtype, e.g., the enkephalins would interact with the 
ô-type, morphine with the y-receptors (see Beaumont and Hughes, 1979). At 
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present, little is known about the relative proportions of these different 
receptors in the CNS. It is of interest, however, that recently Fields 
et al. (1980) have reported that the small diameter PAs in dorsal roots 
and dorsal horn of the spinal cord contain both S- and y-receptors, the 
latter being somewhat more numerous, and Hi Her and Simon (1980) have failed 
to find evidence for the existence of K-receptors in, at least, the rat 
CNS. 
ME action on dorsal horn neurons in the intact cat spinal cord was 
first studied by Duggan et al. (1976, 1977). Applied by iontophoresis, 
ME, methionine-enkephalinamide (ME-amide, a more stable ME analog) and 
morphine altered the extracellularly monitored firing rate of laminae IV 
and V neurons. When applied near the cell bodies of the WDR units, all 
three opiate agonists reduced the spontaneous firing rate and decreased 
the cells' responses to noxious and innocuous skin stimuli. These effects 
were antagonized by iontophoretically, but not intravenously, applied 
naloxone. When the three compounds were administered in the SG (lamina 
II), they were more selective in their action in that responses to noxious 
skin stimuli were reduced to a greater extent than responses to innocuous 
stimuli or spontaneous firing. Naloxone, administered either in the SG or 
intravenously, reversed these effects. The authors suggested that the 
opioid action was due to a presynaptic inhibition of excitatory trans­
mitter release from the terminals of nociceptive PAs, or to a blockade of 
the postsynaptic action of the excitatory PA transmitter on the dendrites 
of laminae IV and V cells, or possibly mediated through an interheuron in 
the SG itself. 
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In another study employing extracellular recordings from spinal 
neurons in vivo, but this time in lamine I-III (the area of highest 
enkephalin and opiate receptor content), we have observed a selective 
inhibitory, naloxone-reversible action of iontophoretically applied ME 
upon units activated principally or exclusively by noxious stimuli. 
Laminae I-III neurons excited by innocuous stimulation of the skin were 
either not affected, or even weakly excited by ME. The peptide thus 
seemed to exert an attenuating influence specifically on spinal nocicep­
tive pathways (Miletic et al., 1977a; Randic and Miletic, 1978b; see Sec­
tion III for more details). 
In the only study to date using intracellular recordings in vivo, 
Zieglgansberger and Tulloch (1979b) confirmed the naloxone-reversible 
inhibition of the spontaneous, synaptically-induced and GLU-evoked activi­
ty of laminae IV and V neurons in the cat spinal cord by iontophoretically 
applied ME and LE. This inhibition was not associated with any detectable 
change in resting potential or input resistance of the membrane. Neither 
spike overshoot nor spike initiation were affected. However, membrane 
depolarization and the associated decrease in input resistance produced by 
GLU were blocked by the enkephalins. Consequently, the authors suggest­
ed that the enkephalins, rather than acting like classical transmitters, 
modulated the excitatory action of GLU by, perhaps, decreasing the rate of 
rise of the excitatory postsynaptic potential (EPSP) through sodium chan­
nel blockade. Electrophysiological studies of mouse spinal neurons in 
culture seem to support such a modulatory role of the enkephalins (Barker 
et al., 1978), as do anatomical observations of their localization in the 
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same neuron with a catecholamine (see Miller and Pickel, 1980). Alterna­
tively, ME and LE may indeed directly hyperpolarize the postsynaptic mem­
brane but at dendritic sites. This effect would not be detectable by the 
distant recording electrode most frequently located inside the soma. Such 
enkephalin action has been observed in guinea pig myenteric neurons in 
vitro (North, 1979). 
The action of the enkephalins need not be confined to postsynaptic 
sites. Indeed, proposals about their effects in the superficial dorsal 
horn center around an inhibitory presynaptic action on PAs. Thus, up to 
50% of the opiate receptors in the monkey dorsal horn appear to be located 
on PA fibers (LaMotte et al., 1976), and ME has been reported to hyper-
polarize PAs in the rat (Evans and Hill, 1978) and to increase the 
threshold for AD activation (and presumably decrease the excitability) of 
single sural Aô and C PAs in the cat (Sastry, 1979a; Randic, unpublished 
observations). In addition, studies of rat sympathetic ganglia in vitro 
(Konishi et al., 1979), chicken sensory neurons in culture (Mudge et al., 
1979) and cat spinal cord dorsal root potentials (DRPs) in vivo (Pomeranz 
and Gurevich, 1979) all suggest an inhibitory, possibly hyperpolarizing 
presynaptic action of the enkephalins. These findings would seem to indi­
cate possible axo-axonic interactions between enkephalinergic neurons and 
PA fibers in the dorsal horn, and thus a role for ME and LE in presynaptic 
modification of sensory input. Very recent anatomical evidence, however, 
fails to confirm such a notion since enkephalinergic fibers are seldom 
seen to form axo-axonic synaptic contacts with SP PAs in the spinal cord 
(de Lanerolle and LaMotte, 1980) or spinal trigeminal nucleus (Sumal 
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et al., 1980). Rather, both the enkphalinergic and SP terminals are seen 
to make mostly axo-dendritic contacts with laminae I-III interneurons. 
Whether the enkephalinergic neurons do exert presynaptic modulation of 
sensory input through nonconventional synapses, i.e., by acting like local 
hormones, as well as through interneurons, remains to be established. 
Unlike most other neuropeptides, the enkephalins have relatively 
specific antagonists which can be used to clarify their role in synaptic 
transmission. Naloxone, the classical opiate antagonist, has been report­
ed to cause excitation of fibers in the DLF (Miletic et al., 1977b) and 
dorsal horn nociceptive neurons (Henry, 1979) in the cat spinal cord, as 
well as to produce hyperalgesia in rats (Woolf, 1980). Since naloxone has 
long been considered a "pure" opiate antagonist having no agonistic action 
by itself, the notion of an endogenous enkephalinergic pain attenuating 
system is given further support by these findings. 
Enkephalins and spinal nociceptive pathways The reason for ex­
pecting ME and LE to have a selective action in spinal nociceptive path­
ways needs no elaboration. It is well-established that the opioids are 
potent analgesics; the opioid peptides were expected to be no less. Thus, 
with the observation of enkephalin cell bodies and fibers in the dorsal horn, 
immediate proposals about an enkephalinergic gating system in the spinal 
cord were put forward. This local gating system, perhaps in concert with 
established descending supraspinal inhibitory pathways, would attenuate 
transmission at the first synapse in spinal nociceptive pathways (e.g., 
see Zieglgansberger, 1980). Soon evidence accumulated to support such a 
notion, and most of this evidence has already been cited above. In addi­
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tion, not as yet cited, opiates have been shown to have a potent and 
direct spinal analgesic action independently of any supraspinal control 
(Yaksh and Rudy, 1976), and ME has been observed to inhibit SP release 
from small diameter, presumably nociceptive PAs (Jessell and Iversen, 
1977). 
It remains to be established whether the enkephalins exert their 
effects by pre- or postsynaptic interactions, and whether they act as 
neurotransmitters and/or neuromodulators. 
Somatostatin 
During their search for growth hormone releasing factor (GHRF), 
Guillemin and colleagues noted powerful and consistent inhibition of 
growth hormone (GH) secretion by some of their hypothalamic extracts. 
Following isolation and purification, the active agent was found to be a 
peptide and was named growth hormone release inhibiting factor (GHRIF) or, 
more simply, somatostatin (Brazeau et al., 1973; Burgus et al., 1973). 
Soon thereafter somatostatin (SS) was synthesized (Rivier, 1974), and 
studies of its distribution and biological actions began. 
SS is a cyclized tetradecapeptide (Ala-Gly-Cys-Lys-Asn-Phe-Phe-
Trp-Lys-Thr-Phe-Thr-Ser-Cys) widely distributed in body tissues. In addi­
tion to being localized within neurons of the central and peripheral ner­
vous systems, the peptide is found in endocrine cells of the thyroid 
gland, pancreas and stomach. In these tissues, SS acts as a hormone and 
similar to its inhibition of GH and thyrotropin release from the anterior 
pituitary, the peptide inhibits the release of thyroxine and triiodo-
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thyronine from the thyroid, insulin and glucagon from the pancreas, and 
gastrin from the stomach (see Efendid et al., 1978). 
For more detailed information about SS actions as a classical hor­
mone and its distribution in various body tissues, the reader is referred 
to the article by Efendic et al. (1978). 
Role of SS in synaptic transmission Within the CNS not only are 
hypothalamic areas such as the median eminence and the periventricular, 
supraoptic, ventromedial and arcuate nuclei, high in SS content, but so 
too are the primary sensory neurons, the subfornical and subcommissural 
organs, the amygdaloid complex, the hippocampus, the prepiriform cortex 
and, particularly, the neocortex (see Efendic et al., 1978). Such uneven 
distribution of SS has generated speculations about the peptide's possible 
involvement in synaptic transmission. Several studies have been under­
taken to determine how SS might satisfy the criteria for central synaptic 
transmitter action, i.e., presence in axon terminals, release upon their 
activation, action on neurons and pharmacological interference with any 
possible effects at the synapse. 
In the rat, presence has been demonstrated in cell bodies and small 
neurons (different from the SP-containing cells, comprising about 10% of 
the total population) in dorsal root ganglia, and in fibers and terminals 
of the spinal dorsal horn (where especially high in content are lamina II, 
Lissauer's tract and adjacent DLF). Dorsal rhizotomy, as with SP, de­
creases markedly the SS content of the dorsal horn suggesting thus axo-
plasmic transport of the peptide from the cell body to axon terminals in 
the spinal cord (Hokfelt et al., 1976). In addition, SS is present in 
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cell bodies and axons in the area of the central canal and the ventral 
horn (Forssmann et al., 1979). 
Subcellularly, SS is concentrated in synaptosomal fractions of brain 
homogenates (Epelbaum et al., 1977; Berelowitz et al., 1978a), as well as 
in synaptic terminals which densely surround neurons in the thalamus, 
hippocampus and neocortex (Petrusz et al., 1977). 
As with SP, not much is known about SS biosynthesis in neurons. 
Polypeptides with SS immunoreactivity but greater molecular weight have 
been isolated from hypothalamic (Zingg and Patel, 1979) and extrahypo-
thalamic (Zyznar et al., 1979) areas, and a 28-amino acid N-terminally ex­
tended SS has been recently sequenced (Pradayrol et al., 1980; Schally 
et al., 1980). These polypeptides might be SS precursors to which SS is 
bound during synthesis or axoplasmic transport to the terminals. An SS-
binding protein has been extracted from cytosol fractions of brain 
homogenates (Ogawa et al., 1977, 1978), but whether this binding protein 
is an SS prohormone or part of the peptide's "receptor" remains to be 
established. 
Little is also known about SS inactivation. Dupont et al. (1978) 
have reported the presence of a peptidase in hypothalamic tissue which 
cleaves SS specifically, showing no affinity for SP or oxytocin. Further 
studies are needed to establish this peptidase as a specific SS-inacti-
vating enzyme. 
Potassium-evoked, calcium-dependent release of SS from hypothalamic 
in vitro slices (Berelowitz et al., 1978b; Iversen et al., 1978), synapto-
somes (Bennett et al., 1979) and cells in culture (Gamse et al., 1980b) 
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has been demonstrated. Potassium-evoked, calcium-dependent release of SS 
from PA terminals in the rat and cat spinal cord in vivo has also been 
observed (Jessell et al., 1979a). 
Action of SS on central neurons has been studied both in vivo and in 
vitro. Applied by iontophoresis in vivo, SS depressed the spontaneous 
firing rate in 80% of the tested hypothalamic neurons. The action was 
brisk in onset and recovery, and the inhibition was often associated with 
an increase in spike amplitude--suggesting hyperpolarization of the post­
synaptic membrane (Renaud et al., 1975, 1976). Similar inhibitory, possi­
bly hyperpolarizing, action of the peptide has been observed in moto­
neurons and PAs of the frog spinal cord (Padjen, 1977) and neurons of the 
guinea pig myenteric plexus (Williams and North, 1978) in vitro, as well 
as in lamine I-III neurons of the cat dorsal horn in vivo (Miletic et al., 
1977a,b; Randic and Miletic, 1978a,b). However, in other in vivo studies, 
neurons in the frontal and parietal cortex, hippocampus and striatum 
(Olpe et al., 1980), as well as corticospinal and other unidentified 
neurons (Phillis and Kirkpatrick, 1980), have been mostly excited by SS. 
Intracellular studies on hippocampal pyramidal units in vitro add to the 
confusion. Dodd and Kelly (1978) reported that iontophoretically applied 
SS strongly excited some of the neurons tested; this excitation was accom­
panied by a depolarization of the neuronal membrane, but with no observa­
ble change in the membrane input resistance. On the other hand, Pittman 
and Siggins (1980) observed a reversible, dose-dependent hyperpolarization 
in 7 of 8 units when SS was introduced into the bathing medium. The 
hyperpolarization was accompanied by a decrease in membrane input re­
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sistance (increase in conductance), and it appeared to be a result of the 
peptide acting directly on the postsynaptic membrane since the effect 
persisted during synaptic transmission blockade (with Mg**-high media). 
Because of the difference in mode of application, both studies need 
further confirmation. 
As with SP, no known specific antagonist of SS actions has been found 
to date. Obviously, much additional work has to be done in order to re­
solve the discrepancies in obtained results. 
SS and spinal nociceptive pathways Because of the peptide's 
presence in 10% of the small cells in spinal ganglia and the superficial 
layers of the dorsal horn, it is conceivable that SS might be a trans­
mitter of primary sensory neurons--perhaps only those signalling nocicep­
tive information? Terenius (1976) has reported that SS acts as a partial 
agonist-antagonist on CNS opiate receptors (SP does not), and, more re­
cently, Rezek et al. (1980) have confirmed an interaction of SS with 
opiate receptors in a radioreceptor assay. Moreover, the latter authors 
observed that intracerebroventricular (icv) injections of SS have a po­
tent, naloxone-reversible antinociceptive action in the rat tail-flick 
test. However, additional data have to be gathered to more fully impli­
cate SS as a transmitter of nociceptive PAs. 
Neurotensin 
While attempting to isolate SP, Leeman and collaborators observed 
that a hypothalamic fraction, different from the one showing sialogogic 
activity, caused marked vasodilation in the exposed cutaneous areas of 
anesthetized rats. Following purification, the active agent was found to 
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be a peptide and was named neurotensin (Carraway and Leeman, 1973). Sub­
sequently, neurotensin (NT) was sequenced and synthesized (Carraway and 
Leeman, 1975a,b), and studies of its distribution and biological actions 
were undertaken. 
NT is a tridecapeptide (pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-
Ile-Leu) found in the CNS and gastrointestinal tract. The peptide's 
biological actions are varied. In vivo NT causes potent vasodilation 
which is associated with transient hypotension and which is accompanied, 
as perhaps secondary phenomena, by increased vascular permeability, stasis 
and cyanosis, hyperglycemia and increased corticosterone, lutenizing hor­
mone (LH) and follicle stimulating hormone (FSH) secretions (see Leeman 
et al., 1977). Injected icv, but not systemically, NT potentiates the 
sedative effects of pentobarbital and causes marked hypothermia. Because 
of this latter effect and the high concentration of NT in areas of the 
hypothalamus considered important for thermoregulatory homeostasis, NT 
could play a physiological role in the regulation of body temperature 
(Bissette et al., 1976). In vitro, as reported recently, NT has a posi­
tive inotropic action on guinea pig atria (Quirion et al,, 1980b) and the 
peptide contracts rat stomach strips, portal vein and coronary vasculature 
(Rioux et al., 1980; Quirion et al., 1980a). 
For a more extensive review of the identification, isolation and 
biological actions of NT, the reader is referred to the article by Leeman 
et al. (1977). The peptide's distribution within the CNS, as determined 
by immunohistochemistry and receptor binding assay, is summarized by 
Snyder et al. (1978). 
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Role of NT in synaptic transmission As determined by radioimmuno­
assay (Carraway and Leeman, 1976; Uhl and Snyder, 1976), receptor binding 
studies (Kitabgi et al., 1977; Lazarus et al., 1977; Uhl et al., 1977a) and 
autoradiography (Young, III and Kuhar, 1979), the highest concentration of 
NT is found in the hypothalamus and brain stem. The uneven distribution 
of NT within the CNS and the observation of specific, high-affinity, 
saturable and reversible NT binding to synaptic membranes--suggestive of 
an association with physiologically relevant receptor sites--gave rise to 
proposals about a possible role of NT in central synaptic transmission 
(Uhl and Snyder, 1977). 
In the spinal cord, NT distribution resembles that of SP, SS and the 
enkephalins (Hokfelt et al., 1976; Snyder et al., 1978). The peptide is 
present at high concentration in cell bodies and unmyelinated axon termi­
nals of laminae I, II and Lissauer's tract (Leeman et al., 1980). It is 
of interest that some of the cell bodies apparently resemble the islet 
cells of Gobel (1978) found in the SG (Seybold and Elde, 1980). In 
addition, some of the NT-containing axons might be of PA origin, and al­
most all NT-containing axons in laminae I and II make axo-dendritic 
synaptic contacts with spinal interneurons (Leeman et al., 1980). NT 
fibers appear also scattered throughout the rest of the dorsal and ventral 
horns (Snyder et al., 1978). 
Subcellulary NT has been localized to synaptosomal fractions (Uhl and 
Snyder, 1976), and visualized by electron microscopy in large (100 nm) 
granular and small (30-40 nm) agranular vesicles within the synaptic 
terminal (Leeman et al., 1980). 
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As with most other neuropeptides, little is known about NT biosynthe­
sis or mode of inactivation. Cathepsin A (Marks, 1977) and a prolyl 
endopeptidase (Orlowski et al., 1979) cleave the peptide at several 
sites, but this action is not specific since SP, SS and other neuropep­
tides will be similarly affected. 
NT release from PA terminals of rat and cat spinal cord has been 
recently reported (Jessell et al., 1979a). This release was potassium-
evoked and calcium-dependent giving further support to the notion of NT 
involvement in synaptic transmission. 
Action of NT on neurons at several levels of the neuraxis is varied. 
In vivo, applied by iontophoresis, the peptide has been reported to cause 
excitation (Zieglgansberger et al., 1978; Miletic and Randic, 1978, 1979), 
or inhibition (Young, III et al., 1978; McCarthy et al., 1979). In vitro 
NT depolarized and excited frog motoneurons (Nicoll, 1978; Phillis and 
Kirkpatrick, 1980), as well as neurons in the guinea pig myenteric plexus 
(Williams et al., 1979) and stria terminalis (Sawada et al., 1980). The 
peptide's action on stria terminalis and myenteric neurons appeared to be 
a direct one exerted on the postsynaptic membrane of the units tested 
since it was not abolished in Ca**-free bathing media. On the other hand, 
TTX greatly reduced the depolarization of frog motoneurons indicating that 
the peptide's action on these units might have been exerted by way of pre­
synaptic connections or interneurons. 
NT is one of few neuropeptides for which a specific antagonist, of at 
least the peripheral effects, has been reported (Quirion et al., 1980c). 
Use of this antagonist, the [D-Trp^^]-NT analog, should be of help in re­
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solving some of the conflicting results obtained to date, as well as in 
establishing a role for NT in synaptic transmission. 
NT and spinal nociceptive pathways Any speculation on the role of 
NT in specifically the nociceptive pathways of the spinal cord rests 
solely on the basis of the peptide's high concentration in laminae I-III 
of the dorsal horn. NT has been reported to have potent antinociceptive 
activity, following icv injections, in the rat tail-flick test (Nemeroff 
et al., 1979); the significance of this finding, however, remains to be 
established. 
Rationale 
It is clear from the literature reviewed that much evidence has 
accumulated to implicate SP, ME, SS and NT as neurotransmitters or neuro­
modulators in synaptic transmission processes at several levels of the 
neuraxis. With respect to the spinal cord, the peptides appear to play an 
important role in areas which are intimately involved in sensory integra­
tion. A better understanding of this role requires a determination of the 
types of excitatory and/or inhibitory interactions occurring at the PA and 
spinal neuronal levels. We considered it important, therefore, to study 
the possible effects that SP, ME, SS and NT might have on the excitability 
of functionally identified spinal neurons. We hoped such study would pro­
vide new, and perhaps valuable, information about the actions of these 
neuropeptides since present knowledge of their physiological function in 
the CNS is minimal. 
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Moreover, we felt that additional and potentially useful information 
could be gained by attempting to determine more precisely the neuropep­
tides' site of action in the dorsal horn. Thus, in order to better under­
stand at which sites, i.e., pre- or postsynaptic, the neuropeptides are 
exerting their main effects, we successfully employed, for the first time 
in studies of peptide actions in the dorsal horn, the rat spinal cord 
slice preparation in vitro. Isolated slices offer several advantages over 
in vivo methods in studies of synaptic transmission. The most notable is, 
perhaps, the possibility of controlling the ionic composition of perfusion 
media. This allows for blockade of synaptic transmission by using media 
with low Ca** and high Mg** concentrations, and helps in determining 
whether a substance acts directly on the postsynaptic membrane, or in­
directly by way of presynaptic interactions or interneurons. However, it 
has to be appreciated that the isolated slice technique has certain dis­
advantages. Most important, perhaps, are the loss of natural input to the 
dorsal horn neurons, and the absence of descending or segmental control 
over their output. The slices may thus very well exhibit some unphysio-
logical properties. Nevertheless, we believed that a judicious combina­
tion of results obtained in vitro and in vivo would enable us to further 
our knowledge of the neuropeptides' role and site of action in the dorsal 
horn of the mammalian spinal cord. 
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SECTION I. EFFECT OF SUBSTANCE P IN CAT DORSAL HORN NEURONS ACTIVATED BY 
NOXIOUS STIMULI^ 
Substance P (SP), a peptide originally isolated from the horse brain 
and gut by von Euler and Gaddum (1931) and recently structurally charac­
terized (Chang and Leeman, 1970), was found at a higher concentration in 
the dorsal than in the ventral roots (Hellauer, 1953; Lembeck, 1953; 
Pernow, 1953; Aitiin et al., 1954). This fact led Lembeck (1953) to suggest 
that SP may be the chemical transmitter released from primary afferent 
(PA) fibers. New support for this concept has been provided by Otsuka and 
collaborators who demonstrated in detailed electrophysiological and bio­
chemical studies that: (1) the highest concentration of SP is present in 
the dorsal horn of the cat spinal cord, the region where the PAs termi­
nate, (2) following ligation and/or sectioning of the dorsal roots, the SP 
level of the dorsal horn is markedly reduced, and (3) exogenously applied 
SP has a depolarizing effect on both frog and newborn rat motoneurons 
(Konishi and Otsuka, 1971; Otsuka et al., 1972; Konishi and Otsuka, 1974; 
Takahashi et al., 1974; Takahashi and Otsuka, 1975). In addition, evi­
dence has been presented that microiontophoretic application of synthetic 
SP has a strong, although slow, excitatory action in about half of the 
units tested in the dorsal horn of the cat spinal cord and cuneate 
nucleus (Krnjevic and Morris, 1974; Henry et al., 1975). Interestingly, 
TPublished as a research paper by Randic, M., and V, Miletic. 1977. 
Brain Res. 128:164-169. ©Elsevier/North Holland Biomedical Press. All 
rights reserved. 
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SP also depolarizes the intramedullary portion of the PAs, although the 
functional significance of this observation is unclear (Nicoll, 1976). 
The cellular localization of SP has recently been examined by immuno-
histochemical techniques by Hbkfelt et al. (1975b, 1976). They have demon­
strated the occurrence of a very dense network of SP-positive fibers par­
ticularly in Lissauer's fasciculus and laminae I-III of the cat lumbo­
sacral spinal cord. In addition, they have found that after local appli­
cation of colchicine, or compression of the dorsal root close to the 
spinal ganglion, SP-positive fluorescence was observed in some of the 
small neuronal cell bodies. In agreement with the bioassay studies of 
Takahashi and Otsuka (1975), they found a marked decrease in the number of 
SP-positive fibers in Lissauer's tract and laminae I-III after a dorsal 
rhizotomy. 
The physiological role of SP-positive fibers in Lissauer's fasciculus 
and laminae I-III is at present unknown. However, there is a recent sug­
gestion that they may be related to pain perception (Henry, 1976). Henry 
has found that microelectrophoretic application of SP to single units, 
located in Rexed's laminae IV-VI of the cat spinal cord, excited about 
half of the units tested. The units activated by noxious thermal stimula­
tion usually responded to one other adequate stimulus as well. If SP is 
involved in excitation of neurons concerned with pain spinal mechanisms, 
its failure to excite all nociceptive neurons is difficult to understand. 
Henry has offered two possible explanations: (1) low rate of SP release 
from the micropipettes, and (2) the possibility that SP is involved in 
neurotransmission at the first afferent synapse and therefore neurons 
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receiving inputs from second or higher order neurons would not be ex­
cited. 
The finding of Hokfelt et al. (1975b, 1976) that the SP-positive 
fibers seem to terminate predominantly in lamina I, where the neurons 
principally or exclusively excited by an input in nociceptor efferent 
fibers have been reported to exist by Christensen and Perl (1970), 
prompted us to study the central effects of SP by applying it microelec-
trophoretically to dorsal horn neurons selectively activated by noxious 
stimuli at the level of Rexed's laminae I-III. The present paper will 
illustrate that SP causes strong excitation of all tested units selective­
ly activated by high threshold mechanical and/or thermal stimuli or by 
afferent volleys in A6 and C fibers, located in laminae I-III. In con­
trast, the units adequately activated by light pressure applied to the 
skin of the tail are either weakly depressed or not affected by SP. The 
preliminary results of our findings were communicated to the Society for 
Neuroscience (Randic and Miletic, 1976). 
The experiments were performed on 20 adult cats initially anesthe­
tized by halothane. The brain was anemically destroyed by bilateral 
occlusion of the common carotid and vertebral arteries. The spinal cord 
was transected at the first cervical level. Thereafter, the animal was 
artificially respired and immobilized by gallamine triethiodide. Body 
temperature, blood pressure and end-tidal COg concentration were monitored 
and maintained at optimal levels throughout the experiment. Laminectomy 
was made at the sacral and caudal spinal levels. A coccygeal dorsal root 
(or rootlet) was freed and placed on a bipolar, stimulating electrode 
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distalTy and a bipolar recording electrode centrally, leaving both 
peripheral and central connections intact. This electrode arrangement 
served for electrical stimulation of the dorsal root and recording of the 
compound action potentials of different kinds of myelinated and unmyeli­
nated afferent fibers. A multiple micropipette was inserted at the root 
entry zone while an electrical stimulus was repeatedly applied to the 
corresponding dorsal root at a rate of 1/second. The electrical stimulus 
was made sufficiently strong so that even the smallest unmyelinated fibers 
in the root were activated. The electrical stimulus thus acted as a 
search stimulus for units activated by afferent volleys conducted in Aô 
and C fiber groups. High intensity mechanical stimuli were delivered to 
the skin of the tail (e.g., pressure from sharply pointed objects; grasp­
ing a fold of skin with calibrated forceps. When the latter type of 
mechanical stimulus was used on human skin, it provoked a highly painful 
sensation). Occasionally, noxious heat (radiant source) was applied to 
the skin of the tail. 
The activity of the dorsal horn neurons in Rexed's laminae I-III, 
selectively activated either by noxious mechanical and/or thermal stimula­
tion or by a volley in Aô or C fibers, was recorded extracellularly 
through the central barrel of a multibarrelled (2- or 3-barrelled) glass 
micropipette filled with a saturated solution of fast green (FCF, 
Matheson, Coleman and Bell) in 3M sodium chloride. The site of recording 
was marked by iontophoresis of the dye. Conventional microelectrophoretic 
technique was used to study the effect of SP (0.5 mg was dissolved in 0.1 
ml of 20 mM acetic acid, giving a final concentration of about 3.7 mM and 
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a pH near 5.5) on the spontaneous and evoked firing of the dorsal horn 
neurons selectively activated by noxious stimuli located in Rexed's 
laminae I-III. A control solution was prepared containing 20 mM sodium 
acetate acidified to a similar pH with acetic acid. The S-barrelled 
micropipettes were allowed to stand at 4°C for 36-48 hrs before experi­
ments. In some experiments, omega-dot triple micropipettes were filled 
with SP prior to the chemical unit analysis. The microelectrophoretic 
unit used contained a current balancing circuit. 
The results of present experiments are shown in Table 1. They are 
based on data obtained from 22 units activated either by noxious mechani­
cal and/or thermal stimulation or by a volley in A6 or C fibers. In addi­
tion, 7 units activated by low threshold mechanical stimulation were 
tested with microelectrophoretically applied SP. SP was applied as a 
cation with currents ranging from 10 to 50 nA for periods up to 2 minutes. 
It is clear from the results presented in Table 1 that all units activated 
either by noxious mechanical and/or thermal stimulation or by a volley in 
AÔ or C fibers located in Rexed's laminae I-III were strongly excited by 
SP. In contrast to this finding, 6 out of 7 cells activated by low 
threshold mechanical stimulation (touching by resting a finger lightly on 
the skin; brushing with a camel hair brush) located in laminae I-III were 
weakly depressed or not affected by microelectrophoretically applied SP. 
Excitation was observed as initiation of firing in a previously quiescent 
cell (Figure 1) or as an increase in the rate of spontaneous firing 
(Figure 2). The on-going firing rate was usually raised 2-20-fold with 
SP. The unit illustrated in Figure 1 did not show any background 
Table 1. Excitatory effects of substance P in cat dorsal horn neurons selectively activated by 
noxious stimuli 
Total number 
of units Input Substance P 
Number of 
units ex­
cited (% of 
total) 
Number of 
units de­
pressed {% 
of total) 
Number of 
units not 
affected (% 
of total) 
22 High threshold 
mechanical and/ 
or thermal 
stimulation 
l-3xlO"^A 100 (2-20-
fold in­
crease 
7 Low threshold 
mechanical 
2-5x10"^A 14 (1.5-
fold in-
57 (slight) 29 
stimulation crease 
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Figure 1. Excitation of a silent lamina I cell (see insert) produced by 
microiontophoretic application of SP (30 nA). Sodium acetate 
(NaAc, 40 nA) is without effect. Unit activity was recorded on 
moving film and the discharge frequence counted 
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i 
i 
g 
-NaAc20- sPIO-
15- h III 
4 
MINUTES 
r 
Figure 2. Excitation of a spontaneously active cell, located on the border zone between laminae II 
and III (see insert) produced by microiontophoretic application of SP (10 and 20 nA) 
Sodium acetate is without effect. 
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activity, however, it was activated by noxious mechanical and thermal 
stimulation of the skin of the tail. A continuous application of SP 
(30 nA) for 1 minute caused excitation within 7 seconds. On turning off 
the current expelling SP, the discharge persisted for more than 1 minute. 
The second application of SP evoked a similar or somewhat larger response. 
"Positive" current of 40 nA applied through the sodium acetate barrel 
consistently failed to elicit a comparable excitatory response. Since the 
sodium acetate solution was prepared at a similar pH as SP, this test also 
practically eliminated a rather unlikely effect of pH. In addition, we 
found that SP produced a facilitation of the response of this unit to 
noxious stimulation. On histological examination of the recording site, 
we found that the unit was located in the marginal cell layer (Rexed's 
lamina I) as illustrated in the insert of Figure 1. 
Another example of SP-produced slow excitation in a spontaneously 
firing unit activated by noxious mechanical stimulation is shown in Figure 
2. Here, a continuous application of SP (20 nA) for 72 seconds caused 
excitation within 16 seconds and a prolonged after-discharge lasting al­
most 2 minutes. The maximum increase in the firing rate in this cell 
ammounted to 363% of the control level. Second application of a smaller 
dose of SP (10 nA) still produced almost a 3-fold increase in the firing 
level. On histological examination of the recording site, the unit was 
found to be located in the border zone between laminae II and III. 
A particularly interesting result is shown in Figure 3 where activity 
of two units located in lamina II, unit A (occasionally responding to low 
threshold mechanical stimulation) and unit B (responding exclusively to 
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Figure 3. Effect of SP (5 nA) on activity of two units located in lamina 
II. A, occasionally responding to low threshold mechanical 
stimulation, was weakly depressed by SP (upper trace). B, 
responding exclusively to high threshold mechanical stimula­
tion, was excited by SP (lower trace) 
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high threshold mechanical stimulation), was simultaneously studied with 
SP. As can be seen from Figure 3, while unit B was excited by SP (5 nA), 
unit A responded with weak depression. 
In conclusion, we have demonstrated in this paper that: (1) ionto-
phoretic application of synthetic SP causes strong excitation of all 
tested units selectively activated by high threshold mechanical and/or 
thermal stimuli or by afferent volleys in Aô and C fibers, located in 
laminae I-III, (2) SP facilitated the responses of the nociceptive neurons 
to adequate stimulation, and (3) the majority of units adequately acti­
vated by light pressure applied to the skin of the tail were either weakly 
depressed or not affected by SP. However, more extensive analysis of 
chemical, anatomical and stimulus specificity of SP excitatory action is 
in progress and will hopefully confirm the preliminary results published 
in this paper. 
The strong excitant effect of SP upon all tested spinal neurons se­
lectively activated by noxious stimuli, located at the level of Rexed's 
laminae I-III, seems to suggest that this peptide may have a physiological 
role of an excitatory transmitter or modulator at the synapses between the 
PA fibers and second order neurons in spinal pain pathways. A similar 
conclusion was reached recently by Henry (1976) who found that micro-
electrophoretic application of synthetic SP to single units, in a differ­
ent population of spinal neurons located in laminae IV-VI of the cat 
spinal cord, causes a slow excitation of approximately half of the noci­
ceptive units tested. If SP is physiologically involved in excitation of 
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neurons concerned with spinal pain mechanisms, its failure to excite all 
nociceptive neurons is difficult to explain. 
This work was supported by PHS Research Grant NSl2972-01, Iowa State 
University Research Foundation and the Salsbury Foundation. 
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SECTION II. EFFECT OF SUBSTANCE P ON CAT DORSAL SPINO­
CEREBELLAR TRACT NEURONS 
This project was part of a more extensive study into the possible 
relationship between morphological features and physiological responses of 
dorsal spinocerebellar tract (DSCT) neurons in Clarke's column (Randic 
et al., 1981). The pharmacological responses of these neurons to ionto-
phoretically applied SP were not included in the material for publication. 
The purpose of the experiments was to provide additional insight as 
to whether SP might be an excitatory transmitter of all primary sensory 
neurons, as suggested by Lembeck (1953) and Otsuka and Konishi (1977), or 
only those involved in nociceptive information signalling. The DSCT 
neurons of Clarke's column were chosen because: (1) PA fibers are mono-
synaptically connected to the DSCT units (Oscarsson, 1965), (2) the inputs 
of DSCT cells from sensory receptors are largely known (Kuno et al., 
1973), (3) the output is also known, i.e., the axons of large DSCT cells 
project rostrally to the cerebellum forming the dorsal spinocerebellar 
tract in the ipsilateral DLF (see Mann, 1973), (4) the DSCT units acti­
vated from a particular peripheral receptor can be accurately identified 
by antidromic (AD) stimulation (Kuno et al., 1973), and (5) a moderately 
dense network of SP fibers is observed around the central canal and in the 
medial parts of laminae V-VII (Hokfelt et al., 1977), the area of the 
Clarke's column (see Mann, 1973). 
Cats (n=7) were surgically prepared as described in the preceding paper 
(Section I) except that two laminectomies, instead of one, were per­
formed: one at the last four cervical (C4-8) or first three thoracic 
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(Thl-3), and the other at lumbar levels (L2-4). The spinal cord was 
transected above the C4 or Thl segments and the left DLF was dissected for 
about 2 cm caudal to the section and placed on a platinum bipolar stimu­
lating electrode. Extracellular recordings from the DSCT neurons were 
performed at the second and third lumbar segments, on the ipsilateral 
side, with the "parallel" microelectrode described in Sections III and IV. 
In order to minimize spinal cord movement during respiration, and in­
crease the mechanical stability for recording, a bilateral pneumothorax 
was routinely performed. DSCT neurons were identified by recording AD 
action potentials following electrical stimulation of the ipsilateral DLF. 
The AD character of a unit's response was determined by: 1) the lack of 
jitter in response latency to repeated simulation at threshold intensity, 
2) the ability to follow repeated stimulation in a 1:1 manner at, or in 
excess of, 100 Hz, and 3) collision of the AD spike with orthodromic 
activity. The physiological characterization of DSCT neurons was done by 
analyzing their responses to a variety of natural (adequate) stimuli ap­
plied to the left hindlimb with intact innervation. Activation of DSCT 
neurons from muscle receptors was tested by applying gentle squeeze or 
pressure to individual muscles, or by stretching the muscles during pas­
sive joint movements of the hindlimb. Identification of cutaneous sensory 
receptor types was primarily based on the criteria described by Burgess 
et al. (1968). According to the type of excitatory PA input, the DSCT 
units analyzed in this project were classified into three groups: 1) 
DSCT-muscle, receiving an input in muscle PAs (la, lb, II) only, 2) DSCT-
cutaneous, activated by hair movement or light touch to the skin or foot­
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pads only, and 3) DSCT-convergent, receiving an input in both muscle and 
cutaneous PAs. SP was applied by iontophoresis, as described in the pre­
ceding paper (Section I). 
The results, summarized in Table 1, are based on data obtained from a 
total of 15 DSCT neurons, 12 of which were classified as DSCT-muscle, 2 
as DSCT-cutaneous and 1 as DSCT-convergent. 
Table 1. Summary of responses of cat DSCT neurons to iontophoretically 
applied substance P 
Group Excited Inhibited No effect 
DSCT-muscle 3 0 9 
DSCT-cutaneous 2 0 0 
DSCT-convergent 0 0 1 
SP, applied as a cation with currents of 20-120 nA for up to four 
minutes, caused excitation in a third (5/15) of the DSCT neurons tested 
(Table 1). In comparison with SP effects on neurons in laminae I-III (see 
Section I), the excitatory response to the peptide was much less promi­
nent. The spontaneous firing rate increased by 2- to 3-fold above control 
levels in only one of the five DSCT units excited by SP (Figure 1). In 
the other four neurons, the excitatory response to SP was slight, and the 
spontaneous firing rate never increased by more than 20% above control 
levels. It is of interest to note that the time course of the peptide's 
effect was of relatively fast onset and recovery in two of the five DSCT 
units excited by SP. This is illustrated in Figure 1 where it can be seen 
that the SP-produced excitation had an onset of about 5 seconds, and that 
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Figure 1. Rate meter record of the lone DSCT unit strongly excited by 
iontophoretically applied SP (30, 40 nA). Positive current of 
twice the magnitude (60 nA), applied through the sodium acetate 
barrel, had no similar effect. Note the fast onset (about 5 
sec), and recovery (about 20 sec) of the SP-produced excita-
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the firing rate recovered to control levels within 20 seconds following 
cessation of SP application. In contrast, the responses of the other 
three DSCT neurons excited by SP, as well as the responses of dorsal horn 
neurons (Henry et al., 1975; Henry, 1976; Randic and Miletic, 1976, 1977), 
were of prolonged onset (10-30 seconds) and recovery (1-3 minutes). It 
has been claimed that the prolonged onset of the SP excitatory response 
was due to an artifact of the iontophoretic technique (Guyenet et al., 
1979). Peptides are not well-ionized at the pH used for iontophoresis, 
and the lower ionization might result in a lower rate of peptide release 
and thus in an artificially long onset of the peptide effect. Whether the 
fast onset seen in the two DSCT units was then a result of SP's rapid re­
lease from the particular pipettes used remains, however, to be further 
clarified. 
This difficulty of ejecting peptides in desirable amounts could also 
have contributed to the small number of DSCT units excited by SP, and to 
the slight excitatory response observed in most of the units that were 
affected by the peptide. In many instances, the pipette ejecting SP 
could not deliver more than 60-70 nA of current due to the common problem 
of "blocking" which, at least in part, results from the low ionization of 
the peptides. The DSCT neurons are large cells, with cell bodies of 75-
100 ym and dendritic trees extending for up to 2 mm from the soma in a 
rostro-caudal direction (Randic et al., 1981). Since in all cases re­
cordings were done near cell bodies, it is conceivable that the amount of 
SP ejected by the small currents (60-70 nA) sometimes used was not suffi­
cient to reach, or saturate, all of the synapses on which PAs terminate. 
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GLU, the ubiquitous and potent excitatory substance, has to be applied 
with at least 50 nA in order to produce excitation of the DSCT units; in 
the dorsal horn, on the other hand, 10 nA will suffice (Randic, unpub­
lished observations). 
These results cannot answer the question as to whether SP is a trans­
mitter, or modulator, of all primary sensory neurons, or only the ones in­
volved in nociceptive information signalling. They justify, however, a 
more extensive analysis of the stimulus-specificity of the SP excitatory 
action. It has been reported that SP caused excitation of lamina IV hair 
units having no apparent nociceptive PA input (Zieglgansberger and 
Tulloch, 1979a). We could not test unambiguously whether the DSCT neurons 
in our sample received an input in nociceptor PAs. However, it is of in­
terest to note that both of the DSCT-cutaneous units were slightly excited 
by SP, although neither appeared activated by hair movement (one had its 
receptive field in pads of the middle toes, the other on the foot). 
In summary: (1) SP excited 5 of 15 DSCT neurons tested in the intact 
cat spinal cord, (2) in most of these units, the excitation was slight 
when compared to the SP-produced excitation in laminae I-III, (3) in some 
of the DSCT units, the excitatory response was of fast onset, and (4) a 
more extensive analysis of the specificity of SP excitatory action is 
needed to establish whether the peptide is a transmitter, or modulator, of 
all primary sensory neurons, or only those involved in nociceptive infor­
mation signalling. 
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SECTION III. DEPRESSANT ACTIONS OF METHIONINE-ENKEPHALIN AND SOMATOSTATIN 
IN CAT DORSAL HORN NEURONS ACTIVATED BY NOXIOUS STIMULI^ 
Enkephalins, the peptides with opiate-like properties, were suggested 
to have a physiological role in the transmission of nociceptive informa­
tion in the CNS (Kosterlitz and Hughes, 1975). Several groups of investi­
gators have studied the responses of single neurons in different CNS re­
gions, including the cat spinal cord, to iontophoretically applied en­
kephalins. In general, these peptides mimic the inhibitory actions of 
morphine (Bradley et al., 1976; Fredrickson and Norris, 1976; Gent and 
Wolstencroft, 1976; Hill et al., 1976; Zieglgansberger et al., 1976), al­
though excitatory actions were observed on Renshaw cells (Davies and Dray, 
1976). Autoradiographic studies in the rat (Atweh and Kuhar, 1977) and 
binding studies in monkey (LaMotte et al., 1976) have shown that particu­
larly laminae I-III of the dorsal horn are rich in opiate receptor binding 
sites. Furthermore, recent immunohistochemical findings suggest that 
enkephalin-containing neurons are numerous in the substantia gelatinosa 
(SG) of the spinal cord (Snyder et al., 1978). Of relevance to the latter 
data are the results obtained by Duggan et al. (1976, 1977) who found that 
methionine-enkephalin (ME) and methionine-enkephalinamide (ME-amide) 
altered the responses of dorsal horn neurons to skin stimuli by acting on 
"opiate" receptors located both on the bodies of dorsal horn neurons 
(laminae IV and V) and some unknown structure in the SG. Thus, they found 
^Published as a research paper by Randic, M., and V. Miletic. 1978. 
Brain Res. 152:196-102. ©Elsevier/North Holland Biomedical Press. All 
rights reserved. 
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that enkephalins applied near cell bodies reduced the spontaneous firing 
and cell responses to noxious and innocuous skin stimuli. These effects 
were antagonized by iontophoretically, although not intravenously, applied 
naloxone. When administered into the SG, with currents considerably high­
er than those used for application near cell bodies, the enkephalins were 
more selective in that responses to noxious skin stimuli were reduced to a 
greater extent than responses to innocuous stimuli or spontaneous firing. 
Naloxone, administered either in the SG or intravenously, reversed these 
effects of the enkephalins. 
Somatostatin, a tetradecapeptide originally isolated from ovine 
hypothalamus as the growth hormone release inhibiting factor (Brazeau 
et al., 1973; Burgus et al., 1973), has been subsequently shown by radio­
immunoassay (Brownstein et al., 1975) and immunohistochemical procedures 
(Dubois et al., 1974; Pelletier et al., 1974; Hokfelt et al., 1975a; King 
et al., 1975; Setalo et al., 1975; Al pert et al., 1976; Hokfelt et al., 
1976) to be widely distributed throughout the mammalian CNS. Somatostatin 
(SS) has potent depressant actions on the excitability of neurons par­
ticularly in the hypothalamus and cerebral cortex (Renaud et al., 1975, 
1976). In the rat spinal cord, the cellular localization of SS-like 
immunoreactivity has been examined by Hokfelt et al. (1975a,1976) who have 
demonstrated the occurrence of SS in small neuronal cell bodies in spinal 
ganglia. In addition, SS-positive fibers were observed in the dorsal horn 
(the highest concentration being in lamina II), Lissauer's fasciculus and 
adjacent areas of the lateral funiculus. Effects of SS examined in frog 
spinal cord indicate that SS acts on both pre- and postsynaptic sites as a 
54 
neuromodulator (Padjen, 1977). The voltage- and calcium-dependent release 
of SS from primary sensory neurons in dissociated cell cultures was re­
cently demonstrated (Mudge et al., 1977). 
The possible physiological functions of ME and SS in the spinal cord 
have not yet been elucidated. Since it is known that superficial laminae 
of the dorsal horn contain neurons principally excited by an input in 
nociceptor afferent fibers (Christensen and Perl, 1970), it was of inter­
est to study the central effects of SS and ME by applying them micro-
iontophoretically to dorsal horn nociceptive neurons, as well as onto 
units activated by sensitive mechanoreceptors. The present paper will 
illustrate that both peptides, ME and SS, have selective depressant ac­
tions on the excitability of nociceptive dorsal horn neurons located in 
laminae I, II and V. In contrast, the majority of the units excited by 
sensitive mechanoreceptors were either not affected or occasionally weakly 
excited by ME and SS. The preliminary results of our findings have been 
communicated (Miletid et al., 1977a,b; Randic and Miletic, 1978a). 
The experiments were performed on 31 adult cats initially anesthe­
tized by halothane. The brain was anemically destroyed by bilateral 
occlusion of the common carotid and vertebral arteries. The spinal cord 
was transected at the first cervical level. Thereafter, the animal was 
artificially respired and immobilized by gallamine triethiodide. Body 
temperature, blood pressure and end-tidal COg concentration were monitored 
and maintained at optimal levels throughout the experiment. Laminectomy 
was made at the sacral and caudal spinal levels. A coccygeal dorsal root 
(or rootlet) was freed and placed on a stimulating electrode distally and 
55 
a bipolar recording electrode centrally, leaving both peripheral and 
central connections intact. This electrode arrangement served for elec­
trical stimulation of the dorsal root and recording of compound action 
potentials of different kinds of myelinated and unmyelinated afferent 
fibers. A multiple micropipette was inserted at the root entry zone while 
an electrical stimulus was repeatedly applied to the corresponding dorsal 
root at a rate of 1/second. The electrical stimulus was made sufficiently 
strong so that even the smallest unmyelinated fibers in the root were 
activated. The electrical stimulus thus acted as a search stimulus for 
units activated by afferent volleys conducted in A5 and C fiber groups. 
High intensity mechanical stimuli were delivered to the skin of the tail 
(e.g., pressure from sharply pointed objects, grasping a fold of skin with 
calibrated forceps. When the latter type of mechanical stimulus was used 
on human skin, it provoked a highly painful sensation). Noxious radiant 
heat (skin heating to above 45°C) was also used. The activity of the 
dorsal horn neurons in Rexed's laminae I-V, activated either by noxious 
mechanical and/or thermal stimulation or by a volley in Aô or C fibers, 
was recorded extracellularly through the recording barrel of a "parallel" 
multibarrelled (2- or 3-barrelled) glass micropipette filled with a solu­
tion of fast green dye in 3M sodium chloride. The site of recording was 
marked by iontophoresis of the dye. The tip of the recording electrode 
protruded by about 5-50 ym beyond the multibarrel led drug-containing 
assembly. Using electrodes of this type, both the size and stability of 
recorded units was greatly improved. Conventional microiontophoretic 
technique was used to study the effects of ME (15 mM in 165 mM NaCl, pH 
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5.5, Bachem; Beckman), ME-amide (8 mM in 165 mM NaCl, pH 5.5, Beckman), 
SS (3.1 mM in 20 mM acetic acid, pH 5.5, Beckman) and naloxone (50 mM in 
165 mM NaCl or distilled water, pH 5.5, Endo Laboratories) ejected as 
cations, on the spontaneous and evoked firing of the dorsal horn neurons. 
Naloxone also was applied intravenously (0.1 mg/kg). A control solution 
was always prepared containing either 20 mM sodium acetate or 165 mM 
sodium chloride at pH 5.5. In all experiments, omega-dot triple micro-
pipettes were filled with drugs prior to the chemical unit analysis. The 
microiontophoretic unit used contained a current balancing circuit. 
The results of present experiments are shown in Table 1. They are 
based on data obtained from 42 units activated either by noxious mechani­
cal and/or thermal stimulation or by a volley in A6 or C fibers. In addi­
tion, 18 units, adequately activated by low-threshold mechanical stimuli 
(touching by resting a finger lightly on the skin; brushing with a camel's-
hair brush) or by volleys of impulses electrically initiated in afferent 
fibers arising from the sensitive mechanoreceptors, were tested with ME 
and SS. When ME or ME-amide (the latter tested only on 6 cells) were 
applied as cations with currents ranging from 20 to 100 nA for periods up 
to 2 minutes, the rate of either spontaneous or noxious stimulation-in-
duced firing was reduced in 22 out of 26 tested cells located in Rexed's 
laminae I and II. The maximum decrease in the firing rate varied between 
29 to 89% of the control level. In contrast to this finding, only 2 out 
of 12 cells excited by sensitive mechanoreceptors were weakly depressed, 
while all the other tested units were either excited or not affected by 
ME. A typical depressant response to ME of a unit activated by both 
Table 1. Summary of responses of cat dorsal horn neurons (laminae I-V) to methionine-enkephalin 
and somatostatin 
Agent No. cells Excited Depressed Nil Naloxone-antagoni sm 
Units activated by noxious stimuli 
Methionine-enkephalin 
Somatostatin 
26 
16 
Units activated by innocuous stimuli 
Methi oni ne-enkephali n 
Somatostati n 
12 
6 
4 
2 
22 
15 
2 
1 
6 
A 
6 (60) 
0 (3D) 
0 (2E, ID) 
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sensitive mechanoreceptors and nociceptors is illustrated in Figure 1. 
When ME was applied with a positive current of 51 nA for 48 seconds, there 
was a latent period of about 12 seconds before a maximal reduction in the 
spontaneous firing rate occurred. On stopping the current, the firing 
rate recovered to the control level within 15 seconds. With repeated or 
prolonged applications, a tachyphylaxis developed in this unit to the 
depressant effect of enkephalin. Since the actual passage of outward 
current may depress the firing of neurons, it is important to distinguish 
between the effects of ME itself and the associated current flow. As 
can be seen in Figure 1, the depressant effect of ME was seen when equal 
iontophoretic current applied through the control barrel (sodium ions) 
even weakly excited the unit. On histological examination of the record­
ing site, we found that the unit was located in the Lissauer's tract, as 
illustrated in the insert of Figure 1. 
Naloxone was used to determine whether the depressant response ob­
served with ME was related to the activation of opiate receptors. Ad­
ministered either by microiontophoresis (14-40 nA) or intravenously (0.1 
mg/kg), naloxone antagonized the depressant effects of both enkephalins on 
spontaneous and noxious stimulation-induced firing in all 6 tested cells, 
although to a various degree in different units. In contrast, the re­
sponses of 3 units excited by innocuous skin stimuli, either excitant or 
depressant, were not affected by naloxone. 
When SS was applied as a cation with current of 20-110 nA for 1-2 
minutes, the rate of either spontaneous or noxious stimulation-induced 
firing was depressed in 15 out of 16 cells. In contrast to this finding. 
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MET-ENKEPHALIN 51 nA 
NaCI 51nA 
2 
MINUTES 
Figure 1. Depression of the spontaneous firing in a wide dynamic range 
unit produced by microiontophoretic application of ME (51 nA). 
Positive current (sodium ions) of the same magnitude produced 
slight excitation. On histological examination of the record­
ing site, the unit was found to lie in the region of Lissauer's 
tract (insert). Unit activity was recorded on moving film and 
the discharge frequency counted 
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the dorsal horn neurons excited by sensitive mechanoreceptors were either 
not affected or occasionally weakly excited by SS. In 3 nociceptive units 
tested, the SS depression was not modified by naloxone (Table 1). The de­
pressant response of a lamina I unit to SS (40 nA) is shown in Figure 2. 
This unit was not spontaneously active, but it was excited by noxious 
mechanical stimulation of the skin of the tail, as well as by a volley in 
AÔ fibers. The characteristics of the depressant response to SS were as 
follows: relatively rapid onset and recovery, depression of rate of fir­
ing frequently was accompanied with an increase in spike amplitude (sug­
gesting membrane hyperpolarization), and there was an absence of similar 
response during application of the control positive current (sodium ions). 
In addition to nociceptive units located in laminae I and II, SS modified 
the spontaneous firing rate of neurons located in the deeper laminae of 
the dorsal horn. Thus, microiontophoretic application of cyclized SS 
(50 nA) produced a 56% reduction in the spontaneous firing rate of a wide 
dynamic range lamina V neuron, as illustrated in Figure 3. Positive cur­
rent of the same intensity, applied through the sodium acetate barrel, was 
without effect. In contrast, SS weakly excited a few nociceptive units 
(responding to both low- and high-threshold mechanical stimulation) lo­
cated in lamina VII of the spinal cord. 
Thus, in conclusion, we have demonstrated in this paper that: (1) 
ME and SS applied microiontophoretically have selective depressant actions 
on the excitability of nociceptive dorsal horn neurons located in laminae 
I, II and V, (2) in contrast, the majority of units excited by sensitive 
mechanoreceptors were either not affected or weakly excited by ME and SS, 
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Figure 2. Depression of noxious stimulation-induced firing (squeezing the 
skin with serrated forceps) in a lamina I unit (see insert) 
produced by microiontophoretic application of cyclized SS (40 
nA). Positive current of 40 nA (sodium ions) was without 
effect (not illustrated). Photographic oscilloscope records of 
extracellular spike potentials from moving film 
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Figure 3. Depression of spontaneous firing in a wide dynamic range lamina 
V unit produced by microiontophoretic application of SS (50 
nA). Positive current (sodium ions) is without effect 
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(3) naloxone, administered either by microiontophoresis or intravenously, 
antagonized the ME depression (to various degrees) in all tested noci­
ceptive neurons while not affecting responses of units excited by sensi­
tive mechanoreceptors; SS depression of nociceptive units was not modified 
by naloxone, and (4) reversal of the depressant effect of ME by naloxone 
indicates that this peptide was probably acting upon specific opiate re­
ceptors. The selective depressant effects of ME and SS upon the majority 
of tested dorsal horn nociceptive neurons located in Rexed's laminae I, II 
and V seems to suggest that ME and SS-containing neurons may physiologi­
cally exert an attenuating influence upon incoming pain information. 
The physiological role of SS-containing primary sensory neurons is at 
present unknown. One of the intriguing possibilities is that SS may have 
the role of an inhibitory transmitter substance at this site. Although 
inhibitory primary sensory neurons have so far not been reported, in­
hibitory mechanisms involved in modulation of the transmission of noci­
ceptive information have been postulated (Melzack and Wall, 1965). Of 
interest, therefore, in this context are our present electrophysiological 
studies suggesting that SS may play an attenuating influence in spinal 
neurons associated with nociceptive pathways. However, an understanding 
of the role of SS in spinal neuronal function requires data on its ultra-
structural localization which will then give information on the neuronal 
nature of SS-containing fibers and synaptology of nerve endings. 
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SECTION IV. NEUROTENSIN EXCITES CAT SPINAL NEURONS LOCATED IN 
LAMINAE I-ni^ 
Neurotensin (NT), a tridecapeptide first isolated from bovine hypo­
thalamus (Carraway and Leeman, 1973) and later characterized and synthe­
sized (Carraway and Leeman, 1975a,b), produces a variety of pharmacological 
effects in vitro and in vivo (Carraway and Leeman, 1973; Leeman et al., 
1977). The localization of NT in specific regions of the CNS, as shown by 
radioimmunoassay (Carraway and Leeman, 1976; Uhl and Snyder, 1976; 
Kobayashi et al., 1977), immunohistochemical technique (Uhl et al., 
1977b) and binding studies (Lazarus et al., 1977; Uhl et al., 1977a), and 
its localization to synaptosomal subcellular fractions (Uhl and Snyder, 
1976) suggest a role in neurotransmission (Uhl and Snyder, 1977). Find­
ings of specific, high affinity, saturable and reversible binding to 
synaptic membranes of rat (Kitabgi et al., 1977; Lazarus et al., 1977; Uhl 
et al., 1977a) and calf (Uhl and Snyder, 1976; Uhl et al., 1977a) suggest 
an association with physiologically relevant NT receptor sites (Uhl et 
al., 1977a). The functions of brain systems that might use NT as a 
mediator, however, are unknown at present. Applied by microiontophoresis, 
onto single neurons, NT has no effect on the spontaneous firing rate of a 
few tested locus coeruleus neurons (Guyenet and Aghajanian, 1977), but 
does produce a slowly developing, powerful excitation of neurons in 
TPublished as a research paper by Miletic, V., and M. Randic. 1979. 
Brain Res. 169:600-604. ©Elsevier/North Holland Biomedical Press. All 
rights reserved. 
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different regions of the brain (Miletic and Randic, 1978; Zieglgansberger 
et al., 1978). 
In the rat spinal cord, NT has been localized to the substantia 
gelatinosa as a particularly dense band of fiber- and terminal-like 
fluorescence in lamina II, with somewhat lower density in lamina I (Uhl 
et al., 1977b). These superficial laminae of the dorsal horn are of 
interest because of their possible role in the transmission of nociceptive 
information. Thus, it is known that they contain neurons principally ex­
cited by an input in nociceptor afferent fibers (Christensen and Perl, 
1970) and are rich in opiate receptor binding sites (Atweh and Kuhar, 
1977). Moreover, substance P, somatostatin and enkephalins are all 
present in high concentrations in this area (Hokfelt et al., 1976; Snyder 
et al., 1978) and have been shown to affect predominantly the nociceptive 
neurons in laminae I-III (Randic and Miletic, 1977, 1978b). It was of 
interest, therefore, to study the central effects of NT by applying the 
peptide onto dorsal horn nociceptive neurons as well as onto units acti­
vated by sensitive mechanoreceptors. The present paper will illustrate 
that synthetic NT produces a slight to moderate excitation of about 2/3 of 
all tested neurons located in laminae I-III. The preliminary results of 
our findings have already been communicated (Miletic and Randic, 1978). 
The experiments were performed on 10 adult cats initially anesthe­
tized by halothane. The brain was anemically destroyed by bilateral 
occlusion of the common carotid and vertebral arteries. The spinal cord 
was transected at the first cervical level. Thereafter, the animal was 
artificially respired and immobilized by gal lamine triethiodide. Body 
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temperature, blood pressure and end-tidal COg concentration were monitored 
and maintained at optimal levels throughout the experiment. Laminectomy 
was made at the sacral and caudal spinal levels. A coccygeal dorsal root 
(or rootlet) was freed and placed on a bipolar stimulating electrode 
distally and a bipolar recording electrode centrally, leaving both 
peripheral and central connections intact. This electrode arrangement 
served for electrical stimulation of the dorsal root and recording of com­
pound action potentials of different kinds of myelinated and unmyelinated 
afferent fibers. A multiple micropipette was inserted at the root entry 
zone while an electrical stimulus was repeatedly applied to the corre­
sponding dorsal root at a rate of 1/sec. The electrical stimulus was made 
sufficiently strong so that even the smallest unmyelinated fibers in the 
root were activated. The electrical stimulus thus acted as a search 
stimulus for units activated by afferent volleys conducted in A5 or C 
fibers. High intensity mechanical stimuli were delivered to the skin of 
the tail (e.g., pressure from sharply pointed objects, grasping a fold of 
skin with serrated forceps; when the latter type of mechanical stimulus 
was used on human skin, it evoked a highly painful sensation). Noxious 
radiant heat (skin heating to above 45°C) was also used. The activity of 
the dorsal horn neurons in laminae I-VII, activated either by noxious 
mechanical and/or thermal stimulation or by a volley in Aô or C fibers, 
was recorded extracellularly through the central barrel of a "parallel" 
multibarrel led (2- or 3-barrelled) glass micropipette filled with a solu­
tion of Fast Green in 3M sodium chloride. The site of recording was 
marked by iontophoresis of the dye. The tip of the recording electrode 
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protruded by about 5-20 ym beyond the multibarrelled drug-containing 
assembly. Using electrodes of this type, both the size and stability of 
recorded units were greatly improved. Conventional microiontophoretic 
technique was used to study the effect of NT (3.0 mM in 20 mM acetic acid, 
pH5.5, Beckman), ejected as a cation, on the spontaneous and evoked firing 
of the dorsal horn neurons. In about half of the studied cells, a unit 
excited by NT also was tested with sodium L-glutamate (GLU - 0.2M, pH 8.0, 
ejected as an anion) in order to ascertain whether NT interacts with post-
synaptically located receptors. In all recordings, a control solution of 
20 mM sodium acetate at pH 5.5 was applied to eliminate any possible 
current or pH artifacts. In all experiments, fiber-containing micro-
pipettes were filled with drugs prior to the chemical unit analysis. The 
microiontophoretic unit used contained a current balancing circuit. 
The results of present experiments are shown in Table 1. They are 
based on data obtained from 33 units, 25 of which were activated by 
noxious and 8 by innocuous stimuli. 
Table 1. Summary of responses of cat dorsal horn neurons (laminae I-III) 
to neurotensin 
Excited No effect 
Units activated by 
noxious stimuli 16 9 
Units activated by 
innocuous stimuli 4 4 
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Of the 25 units activated by noxious stimuli, 7 were of the class 3 
type (excited only by noxious mechanical and/or thermal stimuli or by a 
volley in A6 or C fibers--see Cervero et al., 1976), and 18 of the class 2 
type (activated by nociceptors as well as sensitive mechanoreceptors). 
The 8 units activated by innocuous stimuli were of the class 1 type (ex­
cited by an input in sensitive mechanoreceptors or a volley in A6 fibers). 
In addition to these 33 units, all located in laminae I-III, 10 units (not 
shown in Table 1) of the wide dynamic range type located in deeper dorsal 
horn laminae (IV-VII) also were tested with NT and GLU. 
When NT was applied as a cation with currents ranging from 60-130 nA 
for periods up to 3 minutes, a slight to moderate excitation of about 65% 
of all tested units in laminae I-III was seen. NT proved to possess an 
excitatory action in all categories of neurons recognized in spinal 
preparations of cats in this area on the basis of their excitability by 
different kinds of cutaneous afferent input (Cervero et al., 1976). Thus, 
in contrast to SP, SS and ME, this peptide showed no clear specificity in 
its action towards the nociceptive population of neurons located in 
laminae I-III. 
Excitation was observed as initiation of firing in a previously 
quiescent unit, or as an increase in the rate of spontaneous and/or evoked 
firing (Figures 1 and 2). The excitant response to NT was of relatively 
slow onset and recovery (Figure 1). 
A typical excitatory response to NT of a unit activated by both 
sensitive mechanoreceptors and nociceptors (class 2) is illustrated in 
Figure 1. A continuous application of NT (80 nA) for some 2.5 min pro-
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Figure 1. Excitation of a lamina I unit (see insert) activated both by noxious and innocuous 
stimuli (class 2) produced by microiontophoretic application of NT (80 nA). Positive 
current of 80 nA (sodium ions) was without effect (not illustrated). There is a pause 
of 25 sec between the 1st and 2nd trace, 100 sec between the 2nd and 34d and 65 sec be­
tween the 3rd and 4th. Photographic oscilloscope records of extracellular spike poten­
tials from moving film 
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Figure 2. Excitation of a unit located on the border-line between laminae 
I and II (insert) by NT (130 nA). The unit was activated by an 
input in nociceptor afferents only (class 3b). Positive cur­
rent (sodium ions) of the same magnitude was without effect. 
Unit activity was recorded on moving film and the discharge 
frequency counted 
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duced excitation within 20 sec. Excitation outlasted the period of appli­
cation up to 3 min (range 15-180 sec). Positive current of the same 
magnitude, applied through the sodium acetate barrel, was without effect. 
However, application of GLU (50 nA) caused a marked excitation of this 
unit (not illustrated). As illustrated in the insert of Figure 1, upon 
histological examination of the recording site, we found that the unit was 
located in the marginal layer. 
Another example of NT-produced excitation in a spontaneously firing 
unit activated by an input in nociceptor afferent fibers (class 3b) and 
located on the border between laminae I and II is shown in Figure 2. 
Here, a continuous application of NT (130 nA) for 90 sec caused a slowly 
developing excitation which again outlasted the period of microionto-
phoretic application of the peptide. Positive current of 130 nA, applied 
through the sodium acetate barrel, failed to elicit a comparable response. 
In addition, NT was microiontophoretically applied onto 10 units 
located in laminae IV-VII of the dorsal horn. Although immunohisto-
chemical study revealed some scattered fluorescent fiber- and terminal-
like structures in this area (Uhl et al., 1977b), NT did not modify the 
spontaneous firing rate in any of the 10 tested units. 
GLU caused a marked excitation, of a rapid onset and recovery, in all 
units tested irrespective of the type of input or location in the dorsal 
horn. The excitatory effects of GLU and NT, when applied simultaneously, 
were additive. A similar result was obtained in the rat brain (Zieglgans-
berger et al., 1978). 
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In summary then, we have demonstrated in this paper that: (1) NT, 
applied microiontophoretically, causes a slight to moderate excitation of 
about 65% of all tested units located in laminae I-III; (2) this excita­
tion, characterized by a slow onset and recovery, is not limited to a 
single population of neurons, but is observed in all categories of units 
recognized in spinal preparations of cats in this area on the basis of 
their excitability by different kinds of cutaneous afferent input; (3) NT 
does not modify the spontaneous activity of units located in laminae IV-
VII of the dorsal horn; and (4) GLU excited all tested units in laminae 
I-III that were also excited by NT. Excitatory effects of GLU and NT, if 
applied simultaneously, were additive. 
The temporal characteristics of NT-produced excitation and the re­
sults with GLU are consistent with the possibility that NT acts on post­
synaptic sites in laminae I-III of the spinal cord as a neuromodulator. 
This work was supported by PHS Research Grant NS 12972-01, NSF Grant 
BNS 23871 and the Salsbury Foundation. 
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SECTION V. NEUROPEPTIDES CHANGE THE EXCITABILITY OF DORSAL HORN NEURONS 
IN THE RAT SPINAL CORD SLICE PREPARATION^ 
Since its introduction in electrophysiology (Yamamoto and Mcllwain, 
1966), the in vitro slice technique has been used extensively in studies 
of several brain areas, e.g., olfactory cortex (Richards and Sercombe, 
1968), hippocampus (Skrede and Westgaard, 1971) and cerebellum (Okamoto 
and Quastel, 1973). Physiological and pharmacological responses of the in 
vitro slices appear to be virtually identical to those recorded in intact 
anesthetized animals (see Lynch and Schubert, 1980). In vitro slices 
offer several advantages over the in vivo approach in studies of synaptic 
transmission in the CNS. Most notable, perhaps, is the possibility of 
controlling the ionic composition of the bathing media which then allows a 
more precise location, i.e., pre- or postsynaptic, of a drug's action to 
be determined. In order to extend our previous studies on the role of 
neuropeptides in synaptic transmission processes of the spinal dorsal horn 
(Randic and Miletic, 1977, 1978a,b), we have now employed an in vitro rat 
spinal cord slice preparation. Previous in vitro studies on the pharma­
cology of mammalian single spinal neurons centered mostly on motoneurons 
in either the hemisected spinal cord (Konishi and Otsuka, 1974) or thin 
spinal cord slices (Takahasi, 1978). Preliminary results of our findings 
have already been communicated (Miletic and Randic, 1980). 
^This manuscript will be submitted for publication as a research 
paper by V. Miletic and M. Randic to Brain Research. 
74 
Experiments were performed on 2-35 days old Sprague-Dawley rats. The 
animals were anesthetized with ether and, following a laminectomy, a 1-2 
cm segment of lumbosacral spinal cord, with dura and up to 0.5 cm of 
dorsal rootlets still attached, was excised. The spinal cord segment was 
then quickly cut into transverse 300-800 ym thick slices with a tissue 
chopper or by hand with a razor blade; this latter procedure yielded more 
satisfactory slices showing greater spontaneous activity and longer via­
bility. The slices were then transferred to the recording chamber, which 
was only slightly modified from that of Spencer et al. (1976), placed in a 
fine nylon mesh sandwich, and continuously perfused with warm (32±1°C), 
aerated (95% Og and 5% COg) Krebs solution (105 mM NaCl, 4.7 mM KCl, 2.2 
mM MgSO^, 2.6 mM CaClg, 1.2 mM KHgPO^, 25 mM NaHCOg and 11.7 mM D-glucose, 
pH 7.4) at a rate of about 3 ml/minute. Following an incubation period of 
45-60 minutes, recording commenced. Many dorsal horn neurons showed spon­
taneous activity; those that did not were activated by short pulses (5-
10s) of iontophoretically applied Na-glutamate (0.2M, pH 7.2). Also, 
electrical stimulation of the dorsal rootlet stumps with glass-insulated 
Pt-electrodes (tip exposed some 60 ym, impedance 1-3 Mn at 5 Hz) was used 
to activate silent units or evoke single spikes in spontaneously firing 
neurons (Figure 1). Single unit activity was recorded extracellularly 
with a "parallel" multibarrel led microelectrode filled with fast green dye 
in 3M NaCl. The tip of the recording electrode protruded by 25-75 ym 
beyond the drug-containing assembly. Previous experience showed that by 
using electrodes of this type both the size and stability of recorded 
units was greatly improved (Randic and Miletic, 1978b). Conventional 
5mV 
! 
1 ms 
; • ) 
Figure 1. Extracellularly recorded action potential from a dorsal horn neuron in the rat spinal 
cord slice preparation evoked by electrical stimulation of the dorsal rootlet stump 
(15 V, 0.4 ms, 0.2 Hz; at arrow). Negativity is upward 
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iontophoretic technique was used to apply angiotensin II (Agll, 1.0 mM in 
20 mM acetic acid, pH 5.5, Beckman), cholecystokinin octapeptide (CCK-8, 
4.0 mM in 165 mM NaCl, pH 7.8, Boehringer-Mannheim), methionine-enkephalin 
(ME, 15 mM in 165 mM NaCl, pH 5.5, Beckman), somatostatin (SS, 3.1 mM in 
20 mM acetic acid, pH 5.5, Beckman) and substance P (SP, 3.7 mM in 20 mM 
acetic acid, pH 5.5, Beckman, for iontophoresis or 3.7xlO"^M for bath 
application). In all experiments adjacent barrels of the pipette drug-
assembly routinely contained a solution of 165 mM NaCl or 20 mM sodium 
acetate at pH 5.5 to eliminate any possible current or pH artifacts, and 
IM NaCl to provide a current return path while ejecting the neuropeptides. 
The iontophoretic unit used contained a current balancing circuit. 
Results summarized in Table 1 are based on data obtained from 47 
units recorded in 43 different animals. All neurons were located super­
ficially to lamina VI, as judged by observation of the recording site 
under a stereomicroscope at appropriate magnification (50X). Responses of 
the dorsal horn neurons in the rat spinal cord slice preparation to ionto­
phoretic or bath application of the peptides were qualitatively similar to 
those obtained in previous studies on cat intact spinal cord (Randic and 
Miletic, 1977, 1978b). Thus, ME, applied as a cation with currents of 20-
180 nA for periods up to 2 minutes, produced a depression in the spon­
taneous firing rate in 13 of 14 neurons tested (Table 1). The magnitude 
and time course of the ME effect were similar to those previously reported 
in the in vivo cat spinal cord (Randic and Miletic, 1978b). Figure 2a 
illustrates this depressant effect of iontophoretically applied ME (80 nA) 
on the spontaneous firing rate of a superficially located dorsal horn 
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Table 1. Summary of rat dorsal horn neuron responses to iontophoretic or 
bath applications of neuropeptides 
Peptide No. of cells Excited Depressed Nil 
Substance P 16 15 0 1 
Methionine-enkephalin 14 1 13 0 
Somatostatin 6 0 4 2 
Angiotensin II 8 0 0 8 
Cholecystokinin 7 5 0 2 
neuron. The opioid peptide caused a depression (to 60% of the control 
level) within 6 seconds of the start of the application. The depression 
outlasted the period of application by about 1 minute. Positive current 
(80 nA), applied through the NaCl barrel, was without effect. The de­
pressant effect of ME was not significantly altered when the superfusing 
solution ("normal" Krebs) was replaced with a Ca^^-free, Mg**-high (8 mM) 
bathing medium (Figure 2b). Such Krebs solution blocked synaptic trans­
mission in our preparation as evidenced by the fact that dorsal rootlet 
stimulation became ineffective in evoking activity in the dorsal horn. 
This finding, observed in all six units tried, suggests that ME action 
was a direct one, exerted on postsynaptic sites of the dorsal horn neurons 
in vitro. 
SP, applied as a cation with currents of 10-180 nA for periods up to 
2 minutes (n=13 units), or in the superfusing solution at 3.7xlO"^M (n=3), 
produced excitation in 15 of 16 units tested (Table 1). The magnitude and 
time course of the SP response were similar to that reported previously in 
the intact cat spinal cord (Randic and Miletic, 1977). Figure 3 illus-
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Figure 2a. ME, applied by iontophoresis (80 nA), depressed the spon­
taneous firing of a dorsal horn neuron. Sodium ions, applied 
at same current strength (80 nA) and pH (5.5), are without 
effect. The cell was located in the superficial dorsal horn 
of the rat spinal cord slice preparation. Unit activity was 
recorded on moving film and the discharge frequency counted 
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Figure 2b. ME depression persists when the superfusing solution is re­
placed with a calcium-free, magnesium-high bathing medium. 
This blocks synaptic transmission and the action of the pep­
tide thus appears to be a direct one exerted on the post­
synaptic membrane of the tested neuron. Same unit as in 
Figure 2a 
Substance P 30nA 
24-1 
met-Enk 50nA 
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Figure 3. SP, applied by iontophoresis (30 nA), increases the spontaneous firing rate of a super 
ficially located dorsal horn neuron in a rat spinal cord slice in vitro. Simultaneous 
application of ME (50 nA) suppresses this increase in firing rate 
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trates the excitatory effect of iontophoretically applied SP (30 nA) on 
the spontaneous firing rate of a superficially located dorsal horn neuron. 
It is interesting to note that simultaneous application of ME (50 nA), 
from an adjacent barrel of the iontophoretic pipette, caused a depression 
(reversal to almost control levels) of the SP-produced excitation. This 
effect was observed in all 5 neurons tested. Moreover, in four of these 
units, the effect persisted in a Ca**-free, Mg^^-high bathing medium. 
Such finding would indicate that the observed ME effect did not involve 
presynaptic interactions between ME and SP, but was occurring at post­
synaptic sites of the dorsal horn neurons tested. This observation would 
be in keeping with recent anatomical findings that immunoreactive SP pri­
mary afferents and enkephalinergic fibers in the superficial dorsal horn 
make few axo-axonic synapses. Rather, both are seen to contact spinal 
interneurons through mostly axo-dendritic synapses (de Lanerolle and 
LaMotte, 1980; Leeman et al., 1980; Sumal et al., 1980). 
SS, applied as a cation with currents of 25-75 nA for periods up to 2 
minutes, produced a depression in the spontaneous firing rate in 4 of 6 
neurons tested (Table 1). Figure 4 illustrates this depressant effect of 
SS (50 nA) on a superficially located dorsal horn neuron. As with ME and 
SP, the SS response persisted in Ca**-free, Mg^^-high bathing media. 
AgiI, applied as a cation with current of 100-200 nA for periods up 
to 2 minutes, produced no change in the spontaneous firing rate in any of 
the 8 neurons tested (Table 1). The peptide was also ineffective in ex­
citing neurons which were not spontaneously active but which could be ex­
cited by SP or Na-glutamate applied from adjacent barrels of the ionto-
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Figure 4. Inhibition of the spontaneous firing rate of a superficially 
located dorsal horn neuron in the rat spinal cord slice 
preparation by iontophoretically applied SS (50 nA) 
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phoretic pipette. AgII has been reported to cause excitation of hypo­
thalamic neurons, both in vivo (Wayner et al., 1973) and in vitro (Knowles 
and Phillips, 1979). In the dorsal horn of the adult rat spinal cord, 
Agll seems concentrated in the substantia gelatinosa (SG) (Fuxe et al., 
1976). Our results would indicate that either the putative Agll receptors 
are not present in the newborn animal or, if they are present, that they 
might not be functional. 
CCK-8 results have been already reported as part of another study 
(Jeftinija et al., 1981). Briefly, CCK-8 applied as an anion caused ex­
citation in 5 bf 7 neurons tested (Table 1). This excitation was evident 
as either an increase in the spontaneous firing rate, or as an initiation 
of firing in a previously quiescent unit. The CCK-8 excitation persisted 
in Ca^^-free, Mg^^-high bathing media; this finding suggested that CCK-8, 
like the other neuropeptides in this study, might exert some of its 
effects directly on postsynaptic sites. 
In order to test the effects of SP, ME and SS on the resting membrane 
potential, intracellular recordings were made from a small sample of dorsal 
horn neurons (n=ll). SP caused a dose-dependent depolarization (n=4. 
Figure 5a), while ME (n=3) and SS (n=4. Figure 5b) appeared to hyper-
polarize the membrane of the rat dorsal horn neurons in vitro. Similar 
results, in different neuronal populations studied in vitro, have been 
obtained by others (Barker et al., 1978; Nicoll, 1978; Takahashi, 1978; 
Pittman and Siggins, 1980). 
In summary, we have shown that: (1) responses of dorsal horn neurons 
in the rat spinal cord slice preparation to iontophoretic or bath applica-
Substance P 3x10" M 
Figure 5a. Intracellular recording from a superficially located dorsal horn neuron in the rat 
spinal cord slice preparation. SP, applied into the bathing medium at 3x10" M, 
depolarizes the neuronal membrane. The depolarization appears to be accompanied 
by an increase in membrane input resistance (decrease in conductance) 
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Figure 5b. Intracellular recording from a dorsal horn neuron in vitro. 
SS, applied by iontophoresis (90nA), hyperpolarizes the 
neuronal membrane. This hyperpolarization seems accompanied 
by a slight decrease in membrane input resistance (increase 
in conductance) 
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tion of several neuropeptides were qualitatively similar to those obtained 
in previous studies on intact cat spinal cord, (2) ME, CCK-8, SS and SP 
appeared to act mostly on postsyanptic sites of the dorsal horn neurons 
tested, and (3) the in vitro rat spinal cord slice preperation can be suc­
cessfully utilized for further studies of synaptic transmission processes. 
We are grateful to Drs. K. Lee, R. Finn and G. Lynch for sharing with 
us valuable information about slice preparation as well as the design of 
their recording chamber. We also want to thank Mr. D. Maakestad from our 
depratment for expertly building the slightly modified chamber. 
Supported by NSF Grant BNS 23871, the United States Department of 
Agriculture and the Salsbury Foundation. 
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DISCUSSION 
lontophoretically applied SP was observed to cause a strong excita­
tion of all spinal units in laminae I-III selectively activated by noxious 
mechanical and/or thermal stimuli, while the majority of neurons adequate­
ly activated by innocuous skin stimulation were not affected by the pep­
tide (Section I). These results were in general agreement with those ob­
tained by Henry (1976). In the latter study, however, a different popula­
tion of nociceptive neurons in laminae IV and V was sampled, and of these 
nociceptive neurons only half were excited by SP. As suggested by Henry 
(1976), a possible reason was that the units not affected by SP were 2nd 
or 3rd order spinal neurons receiving polysynaptic rather than monosynap­
tic PA input. Our population of neurons in laminae I-III, on the other 
hand, is considered to receive principally monosynaptic input from small 
diameter PAs (see Willis and Coggeshall, 1978), and it is in these small 
diameter fibers and their terminals in the superficial dorsal horn that SP 
has been localized (Hokfelt et al., 1976; Chan-Palay and Palay, 1977). 
Nevertheless, evidence from both studies would seem to suggest that the 
peptide might have the role of an excitatory transmitter, or modulator, at 
synapses between PAs and dorsal horn neurons in spinal nociceptive path­
ways. 
Still, some caution is needed when such a conclusion is drawn. SP 
has been reported to excite lamina IV hair units having no apparent noci­
ceptive PA input (Zieglgansberger and Tulloch, 1979a). In addition, our 
results following the iontophoretic application of SP onto cat DSCT 
neurons (Section II) indicated that the peptide can cause excitation of 
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units receiving monosynaptic input from muscle or cutaneous PAs which 
probably did not carry nociceptive information. However, in both these 
latter studies the SP-excitatory effect was rather weak when compared to 
the responses of nociceptive dorsal horn neurons, and the total number of 
units affected by the peptide was much smaller. The motion of a relative­
ly selective SP action in spinal nociceptive pathways seems therefore 
supported. 
As to the possible site of SP-excitatory action in the spinal cord, 
previous studies, of frog motoneurons in vitro (Konishi and Otsuka, 1974; 
Nicoll, 1976) and mouse spinal neurons in culture (Vincent and Barker, 
1978), reported a direct, postsynaptic action of the peptide. Our in 
vitro experiments in rat spinal cord slices appeared to confirm these ob­
servations of a postsynaptic site of SP action since the SP-produced ex­
citation was seen to persist in all five units tested when synaptic trans­
mission was blocked by superfusion of the slices with a Ca^^-free, Mg**-
high solution (Section V). This postsynaptic SP action would be con­
sistent with recent anatomical evidence showing that SP-containing PAs in 
laminae I-II contact dorsal horn neurons mainly by way of axo-dendritic 
synapses (de Lanerolle and LaMotte, 1980; Leeman et al., 1980; Sumal et 
al., 1980). Nevertheless, this postsynaptic SP action does not exclude a 
presynaptic effect as well. SP has been observed to cause a prolonged 
excitation of PAs (Nicoll, 1976; Randid and Miletic, 1978a), and to modify 
the electrical excitability of intraspinal cutaneous PAs by producing 
either an increase or a decrease in their threshold for AD activation 
(Randic, 1981). Moreover, the peptide might have an additional modulatory 
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role as well (see Vincent and Barker, 1979), and it is conceivable that in 
such a case, SP need not be dependent upon conventional synaptic contacts 
to exert its physiological role. More studies are obviously needed to 
elucidate the ionic mechanisms and any possible additional sites and/or 
modes of SP action in the spinal dorsal horn. 
lontophoretically applied ME had a selective depressant action on the 
excitability of nociceptive cat spinal neurons located in laminae I, II 
and V (Section III). This inhibitory action of ME was apparently a result 
of binding to specific opiate receptors since the peptide's depressant 
effect was readily reversed by naloxone. Our results were in agreement 
with those of Duggan et al. (1976, 1977) and Zieglgansberger and Tulloch 
(1979b) who also reported selective, naloxone-reversible, inhibitory 
effects of ME, but mostly in laminae IV and V neurons of the cat spinal 
dorsal horn. Data from all three studies thus seemed to provide addi­
tional support for proposals that the opioid peptide might act to selec­
tively inhibit transmission of nociceptive information in spinal pathways. 
The reported selective and opposite effects of SP (Henry, 1976; 
Randic and Miletic, 1976, 1977) and ME (Duggan et al., 1976, 1977; Miletic 
et al., 1977b; Randic and Miletic, 1978b) on spinal nociceptive neurons 
gave rise to suggestions about a possible interaction between the two pep­
tides (see Nicoll et al., 1980). Other studies (see Literature Review) 
had shown that: (1) SP was localized in, and released by, presumably 
nociceptive PAs, (2) some of the opiate receptors in the dorsal horn 
appeared to be located on small diameter PAs usually associated with 
nociception, and (3) ME was localized in dorsal horn interneurons. In 
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addition, it was reported that ME and ME-amide could in fact inhibit the 
potassium-evoked, calcium-dependent release of SP from PAs in vitro 
(Jessell and Iversen, 1977; Mudge et al., 1979). It was reasonable to 
propose, therefore, that by perhaps acting through axo-axonic synapses, 
the enkephalins could attenuate nociceptive information signalling by the 
phenomenon of presynaptic inhibition (see Nicoll et al., 1980). 
Our in vitro data with ME (Section V) appeared to indicate, however, 
that the opioid peptide exerted its inhibitory effects, at least in rat 
spinal cord slices, through a direct action on postsynaptic sites of the 
dorsal horn neurons. The ME inhibitory effect persisted in all six tested 
neurons when synaptic transmission was blocked by Ca**-free, Mg**-high 
bathing media. Moreover, the almost complete reversal of the SP-produced 
excitation by concomitant application of ME also persisted during synaptic 
transmission blockade in all three neurons so tested, suggesting that the 
interaction between SP and ME was occurring at postsynaptic sites of the 
rat dorsal horn neurons as well. This finding would thus not be consis­
tent with the proposal that ME inhibition of spinal nociceptive informa­
tion signalling was achieved only through presynaptic inhibition of the 
presumably SP-containing PAs. 
Although somewhat unexpected, this postsynaptic action of ME is, how­
ever, not unprecedented. The opioid peptide has been reported to directly 
hyperpolarize the postsynaptic membrane of neurons in the guinea pig 
myenteric plexus (see North, 1979) and rat locus coeruleus (Pepper and 
Henderson, 1980) in vitro. Furthermore, recent anatomical evidence would 
seem to support a postsynaptic site of action of the enkephalins, at least 
in laminae I-III. Enkephalinergic fibers, presumably arising from the 
enkephalin-containing spinal interneurons, were seldom seen to form axo­
axonic synapses with SP-containing PAs. Instead, the enkephalinergic and 
SP-ergic fibers were seen to contact other spinal interneurons by way of 
mostly axo-dendritic synapses (de Lanerolle and LaMotte, 1980; Leeman 
et al., 1980; Sumal et al., 1980). It seems conceivable, therefore, that 
ME could attenuate nociceptive information signalling by the mechanism of 
postsynaptic, rather than presynaptic, inhibition. It is of interest in 
this respect that Narotzky and Kerr (1978) have observed that most PAs 
terminate on dendrites of lamina I neurons more distally from the soma 
than do axons arising from spinal interneurons in the SG. The latter 
axons would thus be ideally poised to exert "remote inhibition" (Frank and 
Fuortes, 1957) but at postsynaptic rather than presynaptic sites. This 
type of ME inhibitory action has been observed in guinea pig myenteric 
neurons (see North, 1979), and it is plausible that the ME effect in the 
spinal dorsal horn was a result of a similar type of action. 
As with SP, however, the above suggestion for an ME postsynaptic site 
of action in the spinal dorsal horn needs further confirmation since pre­
synaptic actions of the opioid peptide have also been observed (see 
above). In addition, it is not clear at present whether ME, like SP, 
might have a neuromodulatory action on spinal neurons as well (see 
Barker et al., 1978). If ME action is partly modulatory in nature, then 
the peptide need not be released as a classical transmitter at synaptic 
sites. Rather, its release might be hormone-like and possibly not de­
pendent on conventional synaptic contacts. The presence of opiate re­
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ceptors on at least some PAs appears well-established (LaMotte et al., 
1976), and it is reasonable to assume that the enkephalins bind to these 
receptors and exert a physiological effect. Therefore, although our re­
sults suggest a postsynaptic site of ME action in the spinal dorsal horn, 
we cannot exclude at present an additional presynaptic and/or modulatory 
effect as well. 
Results obtained following the iontophoretic application of SS on 
dorsal horn neurons in both the intact cat spinal cord (Section III) and 
rat spinal cord slices (Section V), seem paradoxical. Classical views of 
excitation and inhibition in the spinal cord hold that monosynaptic PA 
input is exclusively excitatory; inhibition occurs only by way of inhibi­
tory spinal interneurons in di- or polysynaptic pathways (see for example 
review by Schmidt, 1969). Thus, the localization of SS in primary sensory 
neurons (Hokfelt et al., 1976) and our observed inhibitory and postsynap­
tic action of the peptide upon the dorsal horn neurons appears to contra­
dict the classical views. 
Inhibitory actions of SS are, however, not unexpected since they pre­
dominate both within and outside the CNS. Thus, the actions of the pep­
tide in the endocrine system are purely inhibitory (see Ef.endic et al., 
1978), and although both excitatory and inhibitory actions of SS upon CNS 
neurons have been reported, the inhibition is seen exclusively during 
synaptic transmission blockade in vitro. It is only these in vitro 
studies that allow a more precise determination of the peptide's site of 
action. In vivo studies are poorly suited for determining whether an 
action is direct and monosynaptic, or indirect and polysynaptic (see 
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Berry and Pentreath, 1976). Thus, SS has been reported to inhibit and 
hyperpolarize neurons by a direct action on postsynaptic sites persisting 
during synaptic transmission blockade in both the isolated from spinal 
cord (Padjen, 1977) and slices of guinea pig hippocampus (Pittman and 
Siggins, 1980). Although Dodd and Kelly (1978) reported a depolarizing 
and excitatory action of SS in the same population of guinea pig hippo-
campal neurons in vitro, the possibility remains that such action was not 
direct but exerted by way of, perhaps, an inhibitory interneuron since the 
SS action was not tested under conditions of synaptic transmission block­
ade. This inhibition of inhibitory interneurons resulting in excitation 
(termed disinhibition) has been claimed to be responsible for the observed 
excitatory effects of ME in the hippocampus as well (see Zieglgansberger, 
1980). Padjen (1977) also observed some excitatory effects of the peptide 
in the isolated frog spinal cord, but these appeared to be abolished when 
synaptic transmission was blocked. 
It is of additional interest that Light et al. (1979), in their 
systematic study of the superficial dorsal horn, recorded what appeared to 
be PA-evoked inhibitory postsynaptic'potentials (IPSPs) in some units 
located in lamina III. It is to be remembered that laminae II and III are 
areas highest in SS content. Moreover, precedence for PAs to cause hyper-
polarization at the first synapse in a sensory pathway does exist. In the 
retina, some bipolar cells (1st order neurons in this pathway) are hyper-
polarized by receptor cells (the primary sensory neurons in the retina) 
when the latter are activated by light stimuli (see Shepherd, 1979). It, 
therefore, remains a distinct possibility that the input from SS-contain-
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ing PAS is indeed inhibitory. However, additional studies of the precise 
synaptic connectivity of SS afferents in the spinal cord are needed to 
confirm such a possibility and elucidate its possible functional signifi­
cance. 
NT, applied by iontophoresis, also affected the excitability of 
dorsal horn neurons in the cat spinal cord in vivo (see Section IV). 
While the peptide's excitatory action was observed only in laminae I-III 
(not one of the 10 tested laminae IV-VI units was affected by NT), this 
action, in contrast to that of SP, ME and SS, was not limited to only one 
population of spinal units. Rather, NT produced an excitation in all 
three types of neurons recognized in this area on the basis of their ex­
citability by different stimuli. 
In view of recent observations (Seybold and Elde, 1980) that NT . 
containing neurons in laminae I-II morphologically resemble the islet 
cells of Gobel (1978), the observed excitatory effect of NT is somewhat 
surprising. Based on purely morphological criteria, i.e., direction and 
extent of dendritic and axonal arbors, and classical ideas about the func­
tion of SG interneurons (see Willis and Coggeshall, 1978), Gobel (1978) 
proposed that the islet cells are inhibitory spinal interneurons. If 
these cells contain NT, it would be more reasonable to expect for the pep­
tide to have an inhibitory action on the larger, presumably projection, 
neurons most likely recorded from in our study. However, not oîre of the 
33 neurons in laminae I-III or the 10 units in laminae IV-VI that we re­
corded from was inhibited by NT. The peptide would either weakly excite 
a tested unit, or have no effect at all. Moreover, all the NT-activated 
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neurons were also responsive to GLU, and because of the long held view 
that the amino acid acts exclusively at postsynaptic sites, this seemed to 
suggest a postsynaptic site of action of NT. 
Such conclusion, however, warrants caution. It is virtually im­
possible to distinguish unambiguously between pre- and postsynaptic sites 
of action using in vivo preparations (see Berry and Pentreath, 1976). In 
addition, GLU was recently observed to depolarize single sural afferents 
in the cat (Jeftinija and Randic, personal communication); thus, the view 
of its exclusive postsynaptic action might need revision. Moreover, it is 
of interest that the NT-produced depolarization and excitation of frog 
motoneurons in vitro was abolished when synaptic transmission was blocked 
by using tetrodotoxin (TTX) in the superfusing solution (Nicoll, 1978; 
Phi 11 is and Kirkpatrick, 1980). This suggested that the observed excita­
tory action was either due to presynaptic interactions, or to effects ex­
erted through inhibitory interneurons. In view of the reports that NT-
containing axons in laminae I-II contact other spinal interneurons mainly 
through axo-dendritic synapses (Leeman et al., 1980), it is probable that 
the peptide's excitatory effect in the spinal cord was due to action by 
way of an interneuron. 
Inhibitory NT actions of rapid onset and recovery have been described 
in the locus coeruleus (Young et al., 1978) and the nucleus accumbens 
(McCarthy et al., 1979), and a disinhibition phenomenon has been claimed 
to be responsible for the observed excitatory action of ME in the hippo­
campus (see Zieglgansberger, 1980). An alternative, quite plausible, ex­
planation for our observations would thus be that the NT excitatory action 
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was a result of inhibition of an inhibitory spinal interneuron. Obvious­
ly, as with the other neuropeptides, further experimentation is needed to 
clarify whether NT has a neuromodulatory role as well, and whether in such 
a case, conventional criteria for distinguishing the site of a compound's 
action still apply. 
In conclusion, the results presented suggest that SP, ME, SS and NT 
do indeed play a role in synaptic transmission at synapses between PAs and 
dorsal horn neurons in the mammalian spinal cord. Moreover, while SP, ME 
and SS appear to act with relative selectivity at synapses of spinal noci­
ceptive pathways, NT does not show such selectivity. This selective ac­
tion of SP, ME and SS appears to be occurring predominantly at postsynap­
tic sites of the dorsal horn neurons. 
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SUMMARY 
1. The purpose of this project was to examine the possible actions of SP, 
ME, SS and NT on the excitability of functionally identified dorsal 
horn and DSCT neurons in the cat spinal cord in vivo, and dorsal horn 
neurons in rat spinal cord slices in vitro. 
2. Neuronal activity was monitored extracellularly, while SP, ME, SS and 
NT were applied by iontophoresis. 
3. SP caused a strong excitation of all tested units selectively acti­
vated by noxious mechanical and/or thermal stimuli, or by volleys in 
Aô and C PAs, and located in laminae I-III of the intact cat spinal 
cord. 
4. SP facilitated the response of the spinal nociceptive neurons to ade­
quate stimuli. 
5. The majority of units adequately activated by innocuous skin stimuli 
were either weakly depressed or not affected by SP. 
6. SP excited 5 of 15 DSCT neurons tested in the intact cat spinal cord. 
7. In most of these units, the excitation was slight when compared to the 
SP-produced excitation in laminae I-III. 
8. The strong excitant effect of SP upon all tested spinal neurons.selec­
tively activated by noxious stimuli seemed to suggest that this pep­
tide may have the role of an excitatory transmitter, or modulator, at 
synapses between PA fibers and dorsal horn neurons in spinal nocicep­
tive pathways. 
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9. ME and SS had selective depressant actions on the excitability of 
nociceptive cat spinal neurons located in laminae I, II and V. 
10. In contrast, the majority of units excited by sensitive mechano-
receptors were either not affected or weakly excited by ME and SS. 
11. Naloxone, administered either by iontophoresis or intravenously, 
antagonized the ME depression in all tested nociceptive neurons while 
not affecting responses of units excited by sensitive mechanorecep-
tors; SS depression of nociceptive units was not modified by 
naloxone. 
12. Reversal of the depressant ME effect by naloxone indicated that this 
opioid peptide was probably acting upon specific opiate receptors. 
13. The selective depressant effects of ME and SS upon the majority of 
tested spinal nociceptive neurons, located in laminae I, II and V, 
suggested that the ME- and SS-containing neurons may physiologically 
exert an attenuating influence upon incoming nociceptive information. 
14. NT caused a slight to moderate excitation of about 65% of all tested 
spinal units located in laminae I-III. 
15. This excitation, characterized by a slow onset and recovery, was not 
limited to a single population of neurons but was observed in all 
categories of units recognized in this area on the basis of their 
excitability by different kinds of cutaneous input. 
16. NT did not modify the excitability of units located in laminae IV-VII 
of the cat spinal cord. 
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17. GLU excited all tested units in laminae I-III that were also excited 
by NT; the excitatory effects of GLU and NT, if applied simultaneous­
ly, were additive. 
18. These results suggested that NT may play a role in synaptic trans­
mission processes, as a transmitter or modulator, at the level of 
laminae I-III of the cat spinal dorsal horn. 
19. Responses of dorsal horn neurons in the rat spinal cord slice prep­
aration in vitro to SP, ME and SS were qualitatively similar to those 
obtained in studies on the intact cat spinal cord. 
20. Since SP, ME and SS actions persisted during synaptic transmission 
blockade with Ca^^-free, Mg^^-high bathing media, it appeared that 
these neuropeptides were acting predominantly on postsynaptic sites 
of the dorsal horn neurons tested. 
21. The in vitro rat spinal cord slice preparation may be successfully 
utilized for further physiological and pharmacological studies of 
synaptic transmission processes. 
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